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GLOSSARY 
 
 
Cancer: any disease in which abnormal cells divide without 
control with the potential to invade nearby tissues or spread to 
other parts of the body through the blood and lymph systems. 
Chromatin: complex of macromolecules consisting of DNA, 
RNA and proteins that forms chromosomes within the nucleus of 
eukaryotic cells. 
Epigenetics: the study of changes in gene function that are 
mitotically and/or meiotically heritable and that do not entail a 
change in DNA sequence. External modifications to DNA that turn 
genes "on" or "off". 
Gene expression: the process by which information from a gene is 
used in the synthesis of a functional gene product. These products 
are often proteins, but in non-protein coding genes such as transfer 
RNA (tRNA) or small nuclear RNA (snRNA) genes, the product is 
a functional RNA.  
Histones: alkaline proteins found in eukaryotic cell nuclei that 
package and order the DNA into structural units called 
nucleosomes. 
Laminopathies: a group of rare genetic disorders caused by 
mutations in genes encoding proteins of the nuclear lamina. 
Lamins: fibrous proteins providing structural function and 
transcriptional regulation in the cell nucleus. Nuclear lamins 
interact with membrane-associated proteins to form the nuclear 
lamina on the interior of the nuclear envelope. 
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Methylation: the chemical reaction consisting of the addition of a 
methyl group on a substrate. 
microRNA: small non-coding RNA molecule (containing about 22 
nucleotides) found in plants, animals and some viruses, that 
functions as post-transcriptional regulators of gene expression. 
Neuroblastoma: a type of cancer that starts in certain very early 
forms of neural cells found in an embryo or fetus. This type of 
cancer occurs most often in infants and young children. 
Nervous System: the part of an animal's body that coordinates its 
actions and transmits signals to and from different parts of its 
body. 
Nuclear Envelope: a highly regulated membrane barrier that 
separates the nucleus from the cytoplasm in eukaryotic cells. 
Nuclear Lamina: dense fibrillar network inside the nucleus and 
lined with the Inner Nuclear Membrane of most eukaryotic cells. 
Polymerase chain reaction: technique used in molecular biology 
to amplify a single copy or a few copies of a piece of DNA across 
several orders of magnitude, generating thousands to millions of 
copies of a particular DNA sequence. 
Transcription Factors: proteins involved in the process of 
converting, or transcribing, DNA into RNA. 
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SUMMARY 
 
 Lamin A/C are essential components of the nuclear lamina. 
Together with B-type lamins and other structural components, they 
form the network which is located in the inner side of the nuclear 
membrane. It is now clear that lamins exert many different 
functions within the cell, most of them still largely unknown. 
Lamin A/C are absent in embryonic stem cells but are expressed in 
the majority of adult cell types, thereby suggesting their crucial 
role in differentiation. In addition, their expression is reduced or 
absent in several human malignancies, even though their role in the 
tumorigenesis has not been completely characterized yet. A down 
regulation of Lamin A/C could result in increased nuclear 
deformability thereby facilitating transit of cells through the 
capillaries and favouring cell invasive capacity. In a previous paper 
we demonstrated that LMNA gene knock-down inhibits 
differentiation in a cellular model of neuroblastoma and increases 
tumor progression. In this project I investigated some of the 
possible mechanisms by which Lamin A/C is down-regulated in 
neuroblastoma cells. As cellular models I employed two 
neuroblastoma cell lines showing different level of Lamin A/C 
expression (LAN-5 and SH-SY5Y cells). The analysis of the 
nascent transcripts of LMNA gene in both cell lines demonstrated 
that the transcriptional rate of this gene was reduced in the LAN-5 
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cells, indicating that the protein is regulated at transcriptional level. 
In addition, I observed that there is a minor recruitment of Sp1 
transcription factor on the LMNA promoter of LAN-5 cells, as 
evaluated by ChIP assay. Moreover, even though the chromatin 
configuration upstream the LMNA gene promoter is open in both 
cell lines, as evidenced by a similar enrichment of the H3K4me3 
histone marker in both cell lines, we found a different 
configuration in the coding sequence region (CDS), as shown by a 
reduced enrichment in LAN-5 cells of the histone marker 
H3K36me3 which is associated with transcriptional activation. We 
then tried to exogenously express the LMNA gene in LAN-5 cells, 
in which the protein is not detectable. In spite of a very high 
upregulation of LMNA gene, I did not observed any detectable 
expression of Lamin A/C protein. I hypothesized that the protein 
could be regulated by a miRNA-mediated post-transcriptional 
mechanism. An in silico analysis of the miRNAs predicted by 
miRWalk database to significantly target LMNA transcripts, have 
evidenced a unique miRNA, the has-miR-539-5p. However, the 
inhibition of the expression of such miRNA was not able to rescue 
the expression of Lamin A/C protein in LAN-5 cells. At the 
moment I can conclude that the regulation of Lamin A/C protein in 
neuroblastoma cells is mainly to be ascribed to a transcriptional 
mechanism. However, I cannot exclude the existence of an 
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additional regulation mechanism occurring at post-transcriptional 
and/or post-translation level that have to be further investigated.  
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1  INTRODUCTION 
1.1 Nuclear lamins 
In eukaryotes, the inner surface of the NE is lined with a network 
of filamentous proteins forming the nuclear lamina (NL). The NL 
consists of two components, Lamins and nuclear lamin-associated 
membrane proteins. Lamins are type V intermediate filaments (IF). 
They are divided in "A-type" lamins, lamin A and C, expressed 
during development only in differentiating cells, and "B-type" 
lamins, lamin B1 and B2, expressed also in stem cells and essential 
for cell viability (Osmanagic-Myers et al., 2015). The main 
function of the NL is to provide mechanical support to the NE by 
forming a scaffold-like meshwork underlying the inner nuclear 
membrane. The nuclear lamin-associated mediate the attachment 
of the nuclear lamina to the nuclear envelope. The interactions with 
these proteins are pivotal for mitotic nuclear envelope 
disassociation and reassembly, nucleus size and shape, as well as 
correct positioning and spacing of the Nuclear Pore Complexes 
(NPCs). A-type lamins also interact with DNA directly though the 
C-terminus tail (Stierle et al., 2003) or through lamina-associated 
proteins, such as LAP1 and LAP2b or nucleoplasmic LAP2a, and 
this association guides nuclear peripheral positioning and keeps 
constitutive silencing of heterochromatin (Foisner and Gerace, 
1993). Recently, the interaction between LAP2a and lamin A was 
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demonstrated to be capable of promoting proliferation of human 
fibroblasts. Among these Inner Nuclear Membrane associated or 
nucleoplasmic interacting partners, a special group containing 
LEM domains (LAP2, emerin, MAN1 domain) can directly 
interact with BAF (Barrier-to-autointegration factor), suggesting a 
potential role of A-type lamins in the regulation of chromatin 
modification and/or remodeling (Gruenbaum and Foisner 2015). 
These lamins also interact with transcription factors, including Rb, 
SREBP1, MOK2 (Dreuillet et al., 2002) and c-Fos, to regulate 
their activities (Ivorra et al., 2006). 
 
Fig. 1. Nuclear envelope architecture. Nuclear envelope proteins that are 
bound to the lamina include nesprin, emerin, lamina-associated proteins 1 and 2 
(LAP1 and LAP2), the lamin B receptor (LBR) and MAN1. Barrier to 
autointegration factor (BAF) is a chromatin-associated protein that also binds to 
the nuclear lamina and several of the aforementioned nuclear envelope proteins. 
Heterochromatin protein 1 (HP1) binds both chromatin and the LBR. ONM, 
outer nuclear membrane (Liu et al, 2007). 
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1.2 A-type lamin gene 
Number and complexity of A-type lamins increase with metazoan 
evolution. For example, Caernorhabitis elegans has unique gene 
for lamins, lmn-1, expressed in all cells except in mature sperm 
(Liu et al., 2000); Drosophila melanogaster has two genes codifing 
for lamins: lmn Dm0 and lmn C, homologous to A type and B type 
of vertebrate lamins respectively (Bossie and Sanders, 1993). 
LMNA is the gene codifying for A-type lamins, it is on 
chromosome 1 in 1q22 locus, and the gene is formed by 24Kb and 
12 exons. The exon 1 coding for the N-terminal domain and the 
initial portion of the rod domain, the exons 2, 3, 4, 5 and 6 for the 
whole rod domain, the exons 7, 8 and 9 for the C-terminus domain 
including the NLS sequence (Dutta et al., 2016). And the exon 10 
have an alternative splice-site that create the 4 different isoforms of 
A-type lamins existent: Lamin A,  Lamin AΔ10, Lamin C and C2 
(Furukawa et al., 1993). While the isoforms A, AΔ10, C are 
regulated during development and are mainly expressed in 
differentiated cells (Gruenbaum and Foisner 2015) the C2 
isoforms are expressed only in the germ line (Alsheimer et al., 
1999). Mammals have another 2 two genes for lamins, codifying 
for B-type lamins: LMNB1 and LMNB2. LMNB1 is on 
chromosomes 5 in locus 5q23.2-q31.3 and codifying for lamin B1, 
LMNB2 genes is on 19p13.3 locus and codifying for lamin B2 and 
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lamin B3 (Lin and Worman, 1995; Dechat et al., 2008). Lamin B1 
and lamin B2 are regulated and expressed in both embryonic and 
somatic cells during development whereas lamins B3 is regulated 
and expressed only in spermatocytes (Gerace and Blobel, 1980; 
Hutchison, 2002). The increasing complexity of lamins seems to be 
correlated with the increase in the efficiency of nuclear envelope 
disassembly during mitosis (Cohen et al., 2001). Mutations in 
genes for these proteins are associated with several inherited 
diseases. 
 
 
Fig. 2. A-type lamin gene location and structures (Botto et al., 2010). 
 
1.3 Lamin A/C protein structures 
Lamin A/C proteins have a molecular weight of 60-75 kDa and a 
length of 30-100 nm. These proteins are characterized by a not 
structured N-terminus domain, an internal α-helix domain, called 
rod domain (Fisher et al., 1986), and at the C-terminus there are 
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three structures that distinguish lamins from the other members of 
intermediate filaments: a nuclear localization sequence NLS, not 
present in the other members of IF, an immunoglobulin fold, and a 
conserved CAAX box, which consists of a cysteine, two aliphatic 
amino acids and any COOH-terminal amino acid (Davies et al., 
2009; Hermann and Strelkrov, 2011). The α-helix domain is 
necessary to form the coiled-coil dimers, four coiled-coil dimers, 
separated by flexible linkers regions, are associated longitudinally 
head-to-tail to form the highly structured reticular polymer called 
Nuclear Lamina (Hermann and Aebi, 2004). The C-terminus 
domain is an important structure, which allows to extensive post-
translational modification of these proteins to become mature 
lamins. The modifications consist in farnesylation, 
carboxymethylation, sumoylation, ADP-ribosylation (Vidak and 
Foisner, 2016). Phosphorylation of lamins at specific sites is 
instead required at the onset of mitosis to drive disassembly of the 
nuclear lamina (Burke and Gerace, 1986; Foisner and Gerace, 
1993; Mall et al., 2012). 
 
 
Fig. 3. Schematic structure of Lamin A/C proteins. Prelamin A is composed 
of a 28-residue positively charged N-terminal globular domain, a central a-
helical rod-like, a conserved nuclear localization signal (NLS), one Ig-like 
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structure formed by approximately 116 residues on the C-terminus and a 
positively charged C-terminal globular domain. 
 
1.4 Regulation of LMNA gene expression 
1.4.1 Transcriptional regulation 
The coordinated expression of genes drives the cellular processes. 
This coordination is in part regulated by interactions between 
proteins, called transcription factors (TFs) and sequence-specific 
DNA elements, called TF-binding sites (TFBS). These interactions 
regulate gene transcription and expression. The expression of 
LMNA gene is mostly regulated by transcriptional mechanisms, in 
fact the mRNA of LMNA is detected in differentiated cells while is 
absent in embryonic cells (Hamid et al., 1996). The LMNA gene 
of rat has a proximal promoter, which contain several important 
gene activation regions, a GC region at -101, a binding site for 
Sp1/Sp3 transcription factors (TFs), and another region at -7, 
which is a binding site for the transcription factor AP-1. Finally, 
TATA-box is at -33(Tiwari et al., 1998). The importance of these 
regions has been demonstrated by the fact that their mutation 
significantly reduces the activity of the promoter. The Sps 
transcription factors known are Sp1, Sp3 and Sp4. They 
preferentially bind regions rich in GC and GT, with greater affinity 
for the GC regions (Suske, 1999). While Sp1 and Sp3 are present 
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in all tissues, Sp4 is mostly present in nervous tissue. The Sps 
transcription factors can bind the promoter and operate in an 
independently manner, otherwise cooperate synergistically (Bigger 
et al., 1997). It was also shown that the GC regions can be 
controlled by proteins regulated by signaling pathway of retinoic 
acid (RA) (Okumura et al., 2000). It was recently identified a new 
GT region at -55 required for optimal activation of the promoter. 
This region is bound by Sps, which recruit the coactivator 
CBP/p300, showing acetyl transferase activity of H3 and H4 
(Janaki Ramaiah and Parnaik, 2006). The promoter of the rat 
LMNA gene is conserved in humans, with a high homology of GC 
regions, TATA-box and AP-1 (Nakajima and Abe, 1995) and since 
these elements flank the TATA-box region, it is likely that they 
help the binding of the transcription factors, necessary for the 
assembly of transcription complexes (Muralikrishna and Parnaik., 
2001). 
Dottorato di ricerca in Genetica e Biologia Molecolare 
 Pag. 17  
 
Fig.4. Schematic representation of transcription activation by transcription 
factor complexes. OpenStax College, Biology (CC BY 4.0). 
 
1.4.2 DNA methylation  
Research over the past has focused on different molecular 
mechanisms that mediate epigenetic phenomena. The term 
“epigenetic” is used to describe stable and heritable modifications 
that do not involve mutations of DNA sequence, but generate 
functional changes in terms of accessibility of DNA to basal 
replication and transcriptional machineries.  One of most important 
epigenetic phenomena is the DNA methylation of CpG regions. In 
this mechanism, a methyl group is attached to the 5th atom in the 
6-atom ring creating 5-methylcytosine by particular enzymes 
called DNA methyltransferases (DMNTs). The presence of methyl 
groups on cytosine sterically interferes with the binding of 
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transcription factors to consensus sequences, therefore the 
transcription complex in not recruited, while are being recruited 
gene silencing proteins for the chromatin packaging. Agrelo et al. 
demonstrated that the hypermethylation of the LMNA promoter is 
correlated with gene silencing of the region, because the presence 
of the mRNA and the protein is no longer observed. They observed 
the phenomenon in lymphoma and leukemia models. Given that A-
type lamins have an important role either in chromatin protection 
from damages or in regulation of gene expression, it is very likely 
that the absence of nuclear lamins is related to a lack of cell 
differentiation and cancer process progression (Agrelo et al., 
2005). 
 
Fig.5. Skeletal structure for the methylation of methylcytosine to form 5-
methylcytosine, using S-adenosylmethionine as the source of the methyl 
group and giving S-adenosyl-L-homocysteine as product. (Human Genetics 
Unit, Medical Research Council of UK). 
 
1.4.3 Histone modifications 
Other epigenetic mechanisms, which can affect the rate of gene 
expression, are the covalent post translational histone 
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modifications. Histones proteins can undergo a variety of post 
translational modification (PTMs) some of which are methylation, 
acetylation, ubiquitylation, sumoylation and phosphorylation on 
specific amino acid residues. These histone modifications occur at 
several degrees, for example, methylation can be of monomethyl 
(me), dimethyl (me2) and trimethyl (me3). Histone PTMs are 
added on and removed from histones by enzymes, called “writers” 
and “erasers” respectively. Histone acetyltransferases (HATs), 
histone methyltransferases (HMTs) and histone kinases are the 
examples of “writers” which add acetyl, methyl and phosphoryl 
groups, whereas histone deacetylases (HDACs), histone 
demethylases (HDMs) and histone phosphatases are examples of 
“erasers” which remove acetyl, methyl and phosphoryl groups, 
respectively. The mechanism behind the regulation of key cellular 
processes by histone post-translational modifications is not fully 
understood; however, it can be generalized into two categories. 
First, the addition of any PTM on histone proteins affects 
inter/intra-nucleosomal interactions and their binding to DNA by 
steric hindrance or charge interactions. Second, addition of these 
PTMs to histone proteins inhibits or facilitates the binding of 
various proteins to chromatin. These mechanisms allow a vast 
range of flexibility in regulating chromatin dynamics and signaling 
transmission and thereby regulating the gene expression. 
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As an example of first mechanism, histone acetylation is proposed 
to be associated with chromatin remodelling and transcriptional 
activation, H4K16ac inhibits the formation of compact 30 nm 
fibers and higher order chromatin structures. As an example of 
second mechanism, evolutionarily conserved specialized proteins, 
termed “histone readers,” possess the ability to specifically bind 
certain histone modifications and affects a defined nuclear process 
such as transcription, DNA repair and replication, etc. For 
example, through its evolutionary conserved chromodomain 
heterochromatin protein 1 recognize and gets recruited to 
H3K9me3 and H3K27me3 and leads to the formation of compact 
chromatin which in turn inhibits the access of the transcriptional 
machinery. Such complicated and multilayered regulatory 
mechanisms of cellular processes through histone modifications 
have led to the hypothesis of “histone code” where a set of histone 
variants and modifications together perform a specific function. 
However, due to its complexity histone code is still not fully 
understood. Further, the status of one histone modification also 
regulates that of another by cross-talk and affects chromatin 
remodeling and gene expression. Cross-talk between H3S10ph and 
H3K14ac, H2Bub and H3K4me and H3K4ac and H3K4me3 and 
H3K14ac are few prominent examples regulating gene expression 
(Khan SA et al., 2015).  
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Fig. 6. Histones modifications and chromatin architecture. Histones within 
the nucleosome (two each of H2A, H2B, H3 and H4) undergo numerous post-
translational modifications at their N-terminal tails, which protrudes from the 
nucleosome. Further folding of nucleosome with linker histone H1 creates a 
spiral structure, the heterochromatin leading to metaphase chromosome. These 
modifications directly regulate the chromatin structure and thus DNA-mediated 
cellular processes. The diagram indicates some modifications at specific 
residues: M: Methylation; A: Acetylation; P: Phosphorylation. (Khan et al., 
2015). 
 
1.4.4 Post-transcriptional regulation 
The mRNA of LMNA is initially unique, and it is constituted by 
12 exons codifying for the several domain of the protein, there are 
two polyadenylation signals located on exon 10 and exon 12, 
furthermore the exon 10 have an alternative splice site. During 
mRNA maturation alternative splicing mechanism create the four 
existent different isoforms of lamin A/C: lamin A, lamin AΔ10, 
lamin C and lamin C2 (Liu et al., 2008). All isoforms share the 
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nucleotide sequence from exon 1 to exon 9. The isoform A 
contains 9 exons, 90 bases at the 5'exon 10, and exons 11 and 12; 
the C isoform contains 111 bases of exon 10 but not exons 11 and 
12; isoform AΔ10 does not contain exon 10; and the isoform C2 
has an alternative N-terminal encoded from the middle region of 
intron 1 (Barbie et al., 1996). 
 
Fig. 7. LMNA and A-type lamins. The LMNA gene has 12 exons and contains 
two polyadenylation signals, which are located in exon 10 and 12, and are 
utilized by lamin C/C2 and lamin A/A∆10 respectively. As a consequence of 
alternative splicing, the first exon in lamin C2 is different from other A-type 
lamins, and lamin A∆10 shares identical exons with lamin A but lacks exon 10. 
(Liu et al., 2008). 
 
1.4.5 Regulation by microRNAs 
Another mechanism of LMNA gene regulation could be the 
regulation by microRNAs (miRNAs). miRNAs are evolutionally 
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conserved, small non-coding RNAs that are about 19-22 
nucleotides (nt) long. miRNAs modulate gene expression by 
repressing their targets’ translation or inducing mRNA degradation 
through binding to the complementary sequence in target 
messenger RNA. The biogenesis of miRNAs is a complex multi-
step process that starts in the nucleus and ends in the cytoplasm of 
cells. Most miRNAs are transcribed as long monocistronic or 
polycistronic primary transcription units (pri-miRNA) by RNA 
polymerase II. Typically, a pri-miRNA is characterized by a 
hairpin structure, containing a double-stranded (ds) RNA stem of 
∼33 base pairs (bp), a terminal loop, and single-stranded (ss) RNA 
flanking regions. The stem-loop structure contains the miRNA in 
the 5’ or 3’ half of the stem. The pri-miRNA is cleaved in the 
nucleus by a protein complex (the “microprocessor complex”) 
consisting of several proteins including the RNase III enzyme, 
Drosha and its co-factor DGCR8. DGCR8 functions as a molecular 
anchor and defines the binding site for the microprocessor, while 
Drosha cleaves the RNA approximately 11 bp from the ss-dsRNA 
junction, producing the shorter, ∼ 65-70-nucleotide long hairpin 
pre-miRNA. Following completion of this nuclear processing step, 
the pre-miRNA is exported from the nucleus to the cytoplasm by 
the Exportin-5. Here, the pre-miRNA is cleaved by another RNAse 
III enzyme called Dicer. Dicer cleaves ∼22 nt from the pre-
existing end of the pre-miRNA, producing ∼22 nt double-stranded 
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RNA molecules. One of the two strands (the guide strand or 
mature miRNA) is, upon selection by thermodynamic properties, 
loaded on an Argonaute (Ago) protein, the main constituent of the 
RNA-Induced Silencing Complex (RISC). The other strand 
(passenger strand) is degraded. The mature miRNA sequence 
guides the RISC complex to recognize and target partial 
complementary mRNA sequences, primarily within the 3’-
untranslated region (3’UTR) (Kim et al., 2009; Siomi et al., 2009; 
Guarnieri et al., 2008). 
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Fig. 8. miRNA biogenesis pathways and function in gene regulation. (Winter 
et al., 2009). 
 
The mechanisms of miRNA-mediated post-transcriptional 
regulation on target mRNAs include blocking the translation 
and/or inducing the degradation of mRNAs by deadenylation and 
decapping processes. No matter which mechanism predominates, 
the overall output is the reduced amount of protein encoded by the 
target messenger (Bartel, 2009). 
As miRNAs tend to target many different mRNAs, and each 
mRNA may contain several to hundreds of different miRNA 
binding sites, it is obvious that the miRNA-mRNA regulatory 
network is extremely complex. It has been estimated that 30-60 % 
of all human genes are regulated by miRNAs (Lewis et al., 2005; 
Friedman et al., 2009).  miRNA regulation is involved in almost 
all physiological processes, including stem cell self-renewal, 
differentiation, proliferation, metabolism, survival and death 
pathways (Guarnieri et al., 2008; Huang et al., 2011). As a 
consequence of this broad function, miRNA biogenesis has to be 
tightly controlled. Deregulated miRNA expression has been 
associated with a variety of diseases, including cancer. Changes in 
the composition of the nuclear membrane occur during the 
progression of several types of cancers that could be associated to 
miRNA deregulation (Park et al., 2009; Weber et al., 2010).  
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miRNAs are annotated and catalogued in the public-accessible 
web-based database miRBase (www.mirbase.org), which was 
founded at the Sanger Institute in England and is now managed by 
the University of Manchester. So far, more than 5000 mature 
miRNAs have been reported in humans (miRbase, Kozomara et al., 
2014). The miRNA nomenclature is managed by miRBase and has 
been slightly changed with upcoming releases of the database. In 
general, miRNA names start with a 3-4-letter prefix to designate 
the species (e.g. hsa- for Homo sapiens miRNAs). They are further 
assigned by a three-letter prefix, such as miR- or let-, followed by 
a sequential number (e.g., miR-1). In some cases, two mature 
miRNAs are processed from the same stem-loop precursor, one 
from each arm, and are accordingly designated by an additional 
suffix “-5p” (for that released from the 5’-arm) and “-3p” (for that 
released from the 3’-arm); e.g., miR-199a-5p and miR-199a-3p. 
The star-forms (miR*), previously used for minor forms, have been 
“retired” according to the latest nomenclature convention 
(Kozomara et al., 2011). 
 
1.4.6 Post-translational regulation 
Lamins before being incorporated in the nuclear lamina undergo 
post translational maturation processes at the carboxyl domain, 
including covalent modifications such as phosphorylation, 
Dottorato di ricerca in Genetica e Biologia Molecolare 
 Pag. 27  
farnesylation and sumoylation (Prokocimer et al., 2009). The 
precursor peptide of lamin A/C, called prelamin, is processed by 
several cleavage that will culminate in the assembly of the reticular 
polymer of NL (Moir and Goldman, 1993), the half-life of the 
molecular precursor is 90-100 minutes and in about 4 hours is 
acquired and incorporated into the nuclear network (Gerace et al., 
1984). The precursor protein has a farnesylation signal (Clarke, 
1992) on the CAAX-box (Fisher et al., 1993), this feature is absent 
in lamin C (Horton et al., 1992). Then, ZMPSTE24, also known as 
farnesylated-proteins converting enzyme 1 (FACE-1), cleaves 
behind farnesylcysteine to release –AAX (Corrigan, 2005). This is 
followed by methylation on the same cysteine by isoprenylcysteine 
methyltransferase (ICMT). Finally, ZMPSTE24 or other 
unidentified enzymes catalyze a second proteolytic cleavage to 
remove an additional 15 amino acids on the C-terminus (Vidak and 
Foisner, 2015). The mature lamin A is approximately 2 kDa less 
than prelamin A (Agarwal et al., 2003; Corrigan et al., 2005). The 
role of this last step is not clear, however the reaction of first 
isoprenylation is required for all next maturation processes (Holz et 
al., 1989). It is not yet clear where the precursors of lamins are 
processed within the cell, some authors have concluded that the 
maturation occurs at the level of cytoplasm (Kitten and Nigg, 
1991), others affirm that lamins are processed after assembly in the 
network (Gerace et al., 1984). It has been shown that lamins are 
Ilaria Iannetti 
Pag 28  
present within the nucleus in particular in intranuclear foci, as well 
as in perinuclear regions (Sasseville and Raymond, 1995). 
 
 
Fig.9. Post-translational processing of prelamin A.Lamin A is firstly 
synthesized as a precursor with conservedCAAX motif on the C-terminus. Its 
maturation requires mainly four steps. Firstly, the cysteine residue of CAAX is 
farnesylated by farnesyl transferase (FT) located on the endoplasmic reticulum 
(ER). Secondly, Zmpste24 mediates a proteolytic cleavage after farnesyl-
cysteine to release the last three amino acids (AAX). Then the exposed 
farnesylcysteine is further methylated by ICMT. Finally, Zmpste24 mediates the 
second proteolytic cleavage to remove an additional 15 amino acids (Liu et al., 
2008).  
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1.5 Lamin functions 
The main function of the nuclear lamina is to provide support to 
the NE, by forming a scaffold-like meshwork underlying the inner 
nuclear membrane determining the overall shape of the nucleus 
(Gruenbaum and Foisner, 2015). Recent reports showed that 
lamins define the mechanochemical properties of the nucleus 
(Osmanagic-Myers et al., 2015); lamin A is responsible for nuclear 
stiffness, and B-type lamins for nuclear elasticity (Buxboim et al., 
2014; Swift et al., 2013). Besides their mechanochemical role, 
lamins have a multitude of additional functions, including 
chromatin organization, gene regulation, DNA repair, and 
(mechano-) signaling (Amendola and van Steensel, 2014; Andres 
and Gonzalez, 2009; Dechat et al., 2010; Dittmer and Misteli, 
2011; Gruenbaum and Foisner, 2015; Ho and Lammerding, 2012). 
The nuclear lamina is physically connected to the cytoskeleton via 
the linker of nucleoskeleton and cytoskeleton (LINC) complex, 
which plays a crucial role in mechanotransduction (Crisp et al., 
2006). The LINC complex is comprised of SUN (Sad1 & UNC-84) 
domain proteins spanning the Inner Nuclear Membrane (Ketema et 
al., 2013) and is connected to nesprins (also referred to as Syne, 
Myne, and NUANCE) at the Outer Nuclear Membrane (Chang et 
al., 2015). Different isoforms of nesprin also bind actin and 
microtubules and cytoplasmic intermediate filaments (Mèjat et al., 
Ilaria Iannetti 
Pag 30  
2010). Silencing or depleting the components of the LINC 
complex results in nuclear envelop deformities, thereby suggesting 
that these components are necessary to maintain proper shape and 
structure of the nucleus in response to mechanical forces (Cain et 
al., 2014). The many roles of the lamins are mediated by their 
interactions with several proteins of nuclear periphery and 
nucleoplasm such as histone dimers H2A/H2B, the Retinoblastoma 
protein (Rb is a tumor suppressor and a negative cell cycle 
regulator), LAP-2α, Erk kinase-1/2, nuclear actin, PCNA and 
nuclear pore proteins (Hutchison, 2002). Lamin A/C also plays 
essential roles in RNA splicing. Using a nucleoplasmiclamin A/C 
specific monoclonal antibody, LA-2H10, which only stained 
speckles in interphase nuclei without labeling the nuclear rim, 
lamin A/C was reported to co-localize with RNA splicosome, 
indicating its potential role in mediating RNA metabolism 
(Kumaran et al., 2002). Several evidences indicate that lamins are 
also necessary for the replication of DNA, for example Lamins are 
necessary for a correct localization of replication factors such as 
PCNA, during the elongation phase of DNA replication (Moir et 
al., 2000). Lamins also have a role in epigenetic control of gene 
expression because regulate the nuclear chromatin status. It is 
known that lamins bind directly, through the carboxyl terminus, or 
indirectly, by binding other associated proteins, heterochromatin 
(Schirmer and Foisner, 2007). It has been proposed a nuclear 
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architecture model in which lamins are important factors for the 
positioning of chromosomes in the nucleus (Reddy et al., 2008). 
Recently studies demonstrated that there is a crosstalk between 
Lamin A/C protein and the Polycomb group (PcG) a epigenetic 
repressors that control a large number of target genes during 
differentiation (Lanzuolo and Orlando, 2012). In the nucleus, PcG 
proteins form microscopically visible foci (Cmarko et al., 2003), 
and high-throughput data together with microscopy analysis have 
revealed specific organization of their targets in chromatin loops 
(Lanzuolo et al., 2007; Bantignies et al., 2011). In human LMNA-
null cells nuclear positioning of the PcG protein is alterated 
(Masny et al., 2004) demonstrated that lamin A/C can modulate 
transcription through the regulation of PcG protein epigenetic 
factors. On a global level, lamins can influence gene expression 
because they provide the structural scaffolding for the organization 
of the transcriptional complex regulated by RNA polymerase II 
(Dittmer et al., 2014). It has also been described that A-type lamins 
can interact with transcription factors in different ways, capturing 
these molecules in inactive complex, by altering the post-
translational modifications, which are important for their function 
(Gonzalez et al., 2011). 
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1.6 Lamins and Laminopathies 
Since 1999, the year in which it was discovered that a hereditary 
mutation in LMNA gene caused the Emery-Dreifuss muscular 
dystrophy (EDMD) (Bonne et al., 1999), more than 450 diseases 
have been associated with mutations of Lamin A/C, and are 
collectively referred to the term Laminopathies. These disorders 
include Hutchiston-Gilford progeria syndrome (HGPS), dilated 
cardiomyopathy with conduction defect (DCM-CD), the familiar 
partial dystrophy Dunningan (FPLD), the Charcot-Marie Tooth 
(CMTS) and many others (Worman et al., 2015). The high degree 
of tissue-specificity of Lamins A/C and the broad range of diseases 
caused by mutations in the same gene appear to be not clear 
(Shreiber and Kennedy, 2013). Many hypothesis have been 
postulated to explain this: the ‘structural hypothesis’ suggests that 
lamin mutations increase nuclear fragility resulting in cell death 
(Simon and Wilson, 2013). The ‘gene regulation hypothesis’ 
proposes that lamin mutations interfere with tissue-specific genes 
(Peric-Hüpkes et al., 2010). A third hypothesis proposes that lamin 
mutations impair stem cell function such as differentiation bringing 
to defects in proliferation and survival (Chen et al., 2013). These 
hypotheses are not mutually exclusive, and it is likely that 
laminopathies arise from a combination of defects in lamin 
functions.  
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Fig.10. Mutations of LMNA gene and laminopathies. (Broers et al., 2006). 
 
 
 
1.7 Lamins and Cancer 
Recently it was reported that lamins are implicated in many types 
of human cancer, it is clear that A-type lamins are involved in the 
progression of ovarian, lung, prostate, breast, colon and blood 
cancer (De Las Heras et al., 2012). Lamins are involved in the cell 
survival process in two ways: first, they interact with the linker 
protein nesprins, a “bridge” between the nucleoskeleton and the 
cytoskeleton, that transduce the mechanical stress signals coming 
from the plasma membrane to the nuclear membrane 
(Padmakumar et al., 2004). Secondly, they interact with many 
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molecules that regulate cell growth. These proteins have a 
particular binding domain for lamins, called LEM domain, a 
globular module of approximately 40 amino acids, which is mostly 
found in the nucleoplasmic portions of metazoan inner nuclear 
membrane proteins (Wagner and Krohne, 2007), and include 
emerin, the HND1 protein and LAP2α (Dechat et al., 2000). The 
lamin A/emerin complex regulates nuclear accumulation of β-
catenin and the loss of this interaction involves the deregulation of 
β-catenin (Markiewicz et al., 2006), furthermore HND1 and lamin 
A interact with the rSMAD (Lin et al., 2005), and the complex 
lamin A/LAP2α binds the dephosphorylated form of Rb in the 
nucleus. Lacking of the interaction between these molecules causes 
a premature entry into S phase and thus the cell growth in 
fibroblasts (Markiewicz et al., 2002). In colo-rectal cancer it was 
observed that the altered expression of lamins A/C, and especially 
a decreased production of the protein, is associated with increased 
aggressiveness of the cancerous cells and the risk of relapse (Belt 
et al., 2011). The higher invasiveness of these cells can be 
attributed to the fact that lamin A/C has a rule in the metabolic 
pathway of plastins, a actin binding proteins actin (Delanote et al., 
2005). Misregulation of this pathway could mediate down 
regulation of E-cadherin and cell adhesion proteins, phenomenon 
that is closely related to the formation of metastases and tumor 
aggressiveness (Foran et al., 2006). Another possible mechanism 
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that the down regulation of Lamin A/C could result in increased 
nuclear deformability thereby facilitating transit of cells through 
narrow constrictions such as capillaries, and therefore invade 
surrounding tissue to form metastases (Sakthivel et al., 2016). In a 
recent work conducted in neuroblastoma cell lines it has been 
shown that down-regulation of Lamin A/C in human 
neuroblastoma cells leads to a more aggressive tumor phenotype, 
with increased invasive ability and drug-resistance to anticancer 
treatments (Maresca et al., 2012). 
 
1.8 Neuroblastoma 
 
Neuroblastoma (NB) is an extra-cranial heterogeneous tumor of 
the sympathetic nervous system (Esiashvili et al., 2009) and arises 
from developing sympathetic nervous system. Most primary 
tumors localize in the abdomen, the adrenal gland, or lumbal 
sympathetic ganglia (Bottino et al., 2014) The first description of 
pediatric tumors under the term “neuroblastoma” was made by Dr. 
James Homer Wright of the Massachusetts General Hospital as 
early as 1910 (Modak et al., 2010). More than 50% of these tumors 
occur in children less than 2 years of age. The incidence of 
neuroblastoma has increased in recent years and it continues to 
carry a poor prognosis in children over two years of age with a 
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survival of only 38% (Cotterill et al., 2001). Today approximately 
120 new cases are diagnosed in Italy each year, rendering this 
tumor the most common extra-cranial pediatric cancer 
(www.neuroblastoma.org). In 95% of cases, NB is diagnosed 
before the age of 5 years where it leads to 15% of all cancer-related 
fatalities in infancy and childhood (Mueller et al., 2009). Despite a 
century of extensive clinical and basic research efforts, the biology 
and clinical progression of the disease continues to present a multi-
faceted clinical enigma in pediatric oncology. On the one hand, 
neuroblastoma accounts for disproportionate morbidity and 
mortality among the cancers of childhood; on the other hand, it is 
associated with one of the highest proportions of spontaneous and 
complete regression of all human cancers(Brodeur, 2003). The 
most common site for primary NB tumors is the adrenal medulla; 
however, tumors can arise anywhere along the sympathetic branch 
of the autonomic nervous system (Alam et al., 2009). At 
presentation, the disease can be limited to a single organ, locally or 
regionally invasive, or widely disseminated; more than 50% of 
cases are metastatic at presentation (Alam et al., 2009). The most 
common metastatic sites are lymph nodes, bone marrow, bone, and 
liver (Alam et al., 2009). 
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Fig. 11. Clinical Presentations of Neuroblastoma. Neuroblastoma is a 
childhood cancer that is diagnosed at a median age of about 17 months. Tumors 
can arise anywhere along the sympathetic nervous system, with the majority 
occurring in the adrenal medulla. Primary tumors in the neck or upper chest can 
cause Horner’s syndrome (ptosis, miosis, and anhidrosis). Tumors along the 
spinal column can expand through the intraforaminal spaces and cause cord 
compression, with resulting paralysis. Although many lower-stage 
neuroblastomas are encapsulated and can be surgically excised with little chance 
of complications, higher-stage tumors often infiltrate local organ structures, 
surround critical nerves and vessels such as the celiac axis, and are largely 
unresectable at the time of diagnosis. Neuroblastomas typically metastasize to 
regional lymph nodes and to the bone marrow by means of the hematopoietic 
system. Tumor cells metastatic to marrow can infiltrate cortical bone. 
Neuroblastomas also can metastasize to the liver, most notably in patients with 
stage 4S tumors, in whom involvement can be extensive; however, transient and 
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complete regression often occurs with no intervention other than supportive 
care. (Maris et al., 2010). 
1.9 Nervous system development 
The human nervous system consists of the Central Nervous System 
(CNS), comprising the brain and the spinal cord, and the Peripheral 
Nervous System (PNS), which links the CNS with the body’s 
sense receptors, muscles, and glands. The PNS is divided in two 
components: the somatic or skeletal nervous system, which 
controls voluntary movement, and the autonomic nervous system, 
which regulates inner organ function via the sympathetic, 
parasympathetic or enteric ganglia.  
The nervous system originates from the neural plate, an embryonic 
structure evolving from the ectodermal germ layer during the third 
week of gestation.  During the process of neurulation, the neural 
plate invaginates ventrally and closes in order to form the neural 
tube, which will give rise to the CNS. During this closure, neural 
crest cells originate at the interface between the closing neural tube 
and the dorsal ectoderm (LaBonne and Bronner-Fraser, 1999). 
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Fig 12. Nervous system development. After the invagination of the dorsal 
ectoderm, closure of the neural tube, neural crest formation at the interface of 
the closing neural folds and dorsal ectoderm, pluripotent crest cells migrate to 
their destination. (Knecht and Bronner-Fraser, 2002). 
 
The neural tube is initially composed of a single layer of cells. 
However, as development proceeds and extensive cell division 
occurs, the neural tube becomes multilayered, with precursor cells 
dividing in the medial portion of the neural tube adjacent to the 
central cavity, which will give rise to ventricles. The portion of the 
neural tube adjacent to the ventricles becomes the Ventricular Zone 
(VZ) and contains neural stem cells and dividing progenitors 
(Greene and Copp, 2009). These stem cell populations are capable 
of self-renewing through symmetric cell divisions or can 
differentiate through asymmetric cell divisions. The neural tube 
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expands in the head of the embryo to form the brain and in the 
trunk to form the spinal cord. The early mammalian neuraltube is a 
straight structure. However, even before the posterior portion of 
the tube has formed, the most anterior portion of the tube is 
undergoing drastic changes. In this region, the neuraltube balloons 
into three primary vesicles: forebrain (prosencephalon), midbrain 
(mesencephalon), and hindbrain (rhombencephalon). By the time 
the posterior end of the neuraltube closes, secondary bulges—the 
optic vesicles—have extended laterally from each side of the 
developing forebrain. The prosencephalon becomes subdivided 
into the anterior telencephalon and the more caudal diencephalon. 
The telencephalon will eventually form the cerebral hemispheres, 
and the diencephalon will form the thalamic and hypothalamic 
brain regions that receive neural input from the retina. Indeed, the 
retina itself is a derivative of the diencephalon. The mesencephalon 
does not become subdivided, and its lumen eventually becomes the 
cerebral aqueduct. The rhombencephalon becomes subdivided into 
a posterior myelencephalon and a more anterior metencephalon. 
The myelencephalon eventually becomes the medulla oblongata, 
whose neurons generate the nerves that regulate respiratory, 
gastrointestinal, and cardiovascular movements. The 
metencephalon gives rise to the cerebellum, the part of the brain 
responsible for coordinating movements, posture, and balance 
(Gilbert, 2000). 
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Fig 13. Early human brain development. The three primary brain vesicles are 
subdivided as development continues. On the right is a list of the adult 
derivatives formed by the walls and cavities of the brain. Gilbert, 2000. 
The cerebellum is one of the best studied parts of the brain. The 
cerebellar cortex is composed of four main types of neurons: 
granule cells (GCs, the most numerous neurons of the entire central 
nervous system), Purkinje cells (PCs) and two types of inhibitory 
interneurons, the Golgi cells and the stellate/basket cells. The 
cerebellum develops over a long period, extending from the early 
embryonic period until the first postnatal years. The main cell 
types of the cerebellum arise at different times of development and 
at different locations. The PCs and the deep cerebellar nuclei arise 
from the ventricular zone of the metencephalic alar plate, whereas 
the GCs are added from the rostral part of the rhombic lip, known 
as the upper rhombic lip. The rhombic lip, is the dorsolateral part 
of the alar plate, and it forms a proliferative zone along the length 
of the hindbrain. Cells from its rostral part reach the superficial 
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part of the cerebellum, and form the external germinal or granular 
layer (EGL) at the end of the embryonic period. Granule cells are 
formed in the EGL. The granule cells form axons, the parallel 
fibres, and migrate along the processes of Bergmann glia cells 
(BGCs) to their deeper, definitive site, the internal granular layer 
(IGL).  In the fetal period, the IGL is formed by further 
proliferation and migration of the external germinal cells. This 
layer, situated below the layer of Purkinje cells, is the definitive 
granular layer of the cerebellar cortex. A transient layer, the lamina 
dissecans, separates the IGL from the Purkinje cells. Ultimately, it 
is filled by migrating granule cells and disappears (Rakic and 
Sidman, 1970). During the inward migration of the postmitotic 
granule cells (16–25 weeks), the Purkinje cells enlarge and develop 
dendritic trees (Milosevic and Zecevic, 1998; Miyata et al., 1999). 
The EGL appears at the end of the embryonic period and persists 
for several months to 1–2 years after birth (Lemire et al., 1975). 
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Fig 14. Differentiation of cerebellar cortical neurons. GCs (light red) arise (1) 
from granule cell precursor cells (GCPs) in the external granular layer (EGL), 
migrate in several steps (2–7) along the dendrites of Bergmann glia cells (BGCs) 
to the internal granular layer (IGL).The development of PCs (red) also involves 
several steps (a–e). (Hatten et al., 1997). 
 
Neural crest cells delaminate from the neural tube and migrate 
extensively throughout the embryo to generate, differentiate, and 
populate numerous organs.  During this migration, neural crest 
cells undergo differentiation and form Schwann or glial cells, 
melanocytes, and sympathoadrenal progenitor cells. From these 
sympathoadrenal progenitor cells is derived the sympathetic 
nervous system (SNS). SNS’s special feature relates to the 
organism’s “fight or flight” response. There are three types of cells 
present in the SNS: chromaffin cells (adrenal medullary cells), 
small intensely fluorescent cells, and sympathetic neurons (known 
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as neuroblasts during embryogenesis). The migrating neural crest 
cells are influenced by the molecular guidance given by various 
external factors and ligands acting on the receptors present on the 
surface of the neural crest cells. The morphology, differentiation, 
and derivatives of the neural crest cells are also mediated by local 
tissue interactions. Genetically regulated cell-autonomous factors 
or exposure to environmental factors result in disturbances of 
differentiation, which then give rise to uncontrolled cell cycle or 
ectopic tissue formation. Disturbances in neural crest cell 
regulation are involved in different serious diseases such as 
neuroblastoma (Takahashi et al., 2013; Etchevers et al., 2006). 
 
 
1.10 Genetics of neuroblastoma 
 
Neuroblastoma may be considered a malignant manifestation of 
aberrant sympathetic nervous system development. Until recently, 
however, little was known about the genetic basis of this disease. 
As has been shown for many human cancers, a subgroup of cases 
display autosomal dominant inheritance (Knudson and Strong, 
1972). Mossé and colleagues reported that activating mutations in 
the tyrosine kinase domain of the ana-plastic lymphoma kinase 
(ALK) oncogene account for most cases of hereditary 
neuroblastoma (Mossé etal., 2008). These germline mutations 
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encode for single-base substitutions in key regions of the kinase 
domain and result in constitutive activation of the kinase and a 
premalignant state. Mutations resulting in oncogene activation are 
also somatically acquired in 5 to 15% of neuroblastomas (Mossé et 
al., 2008; Chen et al., 2008). In humans, ALK is located on 
chromosome 2p23 and the gene encodes for a single-chain 
transmembrane protein. ALK is a member of the insulin receptor 
(IR) superfamily of receptor tyrosine kinases, which shows 
homology with the leukocyte tyrosine kinase, the insulin-like 
growth factor-1 receptor kinase and the IR kinase.  The 
mutated/amplified full-length ALK leads to cell growth and 
survival by the activation of the JAK–STAT, PI3K–AKT or RAS–
MAPK pathways (Azarova et al., 2011). Children with either 
sporadic or familial neuroblastoma in conjunction with congenital 
central hypoventilation syndrome, Hirschsprung’s disease, or both 
usually have loss-of-function mutations in the homeobox 
gene PHOX2B (Mossé et al., 2004; Trochet et al., 2004). Thus, 
genetic testing for mutations in ALK and PHOX2B should be 
considered whenever a patient has a family history of 
neuroblastoma or has other clinical conditions that are strongly 
suggestive of a highly penetrant transmissible mutation, such as 
bilateral primary tumors of the adrenal glands.  
Such testing is currently available to practitioners 
(www.ncbi.nlm.nih.gov/sites/GeneTests). 
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Although ALK and PHOX2B mutations account for the majority of 
familial cases of neuroblastoma, additional familial genes may still 
be discovered.In sporadic neuroblastoma cases, malignant 
transformation probably arises from the interaction of common 
DNA variants in which each individual variation has a relatively 
modest effect on susceptibility. A genomewide association study of 
neuroblastoma is currently under way, under the auspices of the 
Children’s Oncology Group (COG). To date, the study has shown 
that alleles with common single-nucleotide-polymorphism 
variations within the putative genes FLJ22536 at chromosome 
band 6p22.3 and BARD1 (BRCA1-associated RING domain 1) at 
2q35 are significantly enriched among patients in whom 
neuroblastoma has developed as compared with controls (Capasso 
et al., 2009; Corallo et al., 2016). In addition, the study has also 
shown that a relatively common copy-number variation at 1q21 is 
associated with the development of neuroblastoma (Diskin et al., 
2009). Tumor-derived genomic information has been used since 
the 1980s to predict the course of newly diagnosed 
neuroblastomas, with the discovery that the MYCN oncogene is the 
target of the extremely high-level amplifications at chromosome 
band 2p24 observed in about 20% of neuroblastoma cases (Zhu 
and Thomas Look, 2016). MYCN belongs to a family of oncogenes 
called Myc oncogene-family members, whose most studied 
member is the MYC oncogene and include also MYCL oncogene. 
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They are transcription factors, which activate, together with their 
dimerization partner Max, gene expression of a number of genes in 
an E-box dependent manner. MYCN and MYC have very similar 
molecular functions (Bonnet et al., 1997). The Myc oncogene-
family members are involved in cell growth through protein 
synthesis, transcriptional regulation of ribosomal RNA processing, 
cell adhesion and tumor invasion. A real breakthrough in the 
search for genomic alterations that impact on NB aggressiveness 
comes from the recent observation of telomerase reverse 
transcriptase (TERT) activation by genetic rearrangements in high-
risk NB. By whole-genomic sequencing of 59 NB cases the authors 
discovered recurrent genetic rearrangements in the chromosomal 
region 5p15.33 proximal of TERT. Rearrangements of this region 
took place only in high-risk Neuroblastoma (Peifer et al., 2015).  
Taken together, these observations suggest that this developmental 
childhood cancer is influenced by common DNA variations, 
facilitating the development of a putative genetic model for this 
disease. 
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2 AIM 
 
 
Some advanced tumors often exhibit reduced expression of lamin 
A/C, even though the mechanisms underlying this downregulation 
are not yet completely deciphered. Lamins support the nuclear 
envelope and provide anchorage sites for chromatin; they are also 
involved in DNA synthesis, transcription, and apoptosis. The 
involvement of the lamins in the processes of tumor progression, 
and of subsequent metastasis, may be related to an increased 
nuclear deformability, which facilitates transit of cells through 
narrow constrictions such as capillaries. Moreover, lamins can 
interact with adhesion proteins, such as e-cadherins and nesprins, 
and could therefore be involved in the process of metastases 
formation. The aim of my PhD project was to study the possible 
mechanisms by which Lamin A/C is downregulated in tumors of 
neural origin and in particular in neuroblastoma. Based on our 
previous data from my laboratory showing that LMNA gene 
knock-down inhibits differentiation in a cellular model of 
neuroblastoma and promote tumor progression by increasing cell 
motility and invasion in vitro and tumorigenicity in vivo, I 
investigated different mechanisms of regulation of the Lamin A/C 
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expression. As experimental model, I used the SH-SY5Y and 
LAN-5 human neuroblastoma cell lines expressing different level 
of LMNA gene. To date I studied the transcriptional regulation of 
LMNA in terms of histone modifications and TFs recruitment in 
LAN5 cell line compared to SHSY5Y. Moreover, I also studied the 
mechanism of regulation of the protein mediated by microRNAs. 
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3 RESULTS 
 
Lamin A/C expression in neuroblastoma samples and 
established cell lines. We have first analyzed by real time PCR the 
expression of LMNA gene in a cohort of 30 patients with 
neuroblastoma at different disease stage. We observed a very high 
heterogeneity with few tumors expressing LMNA gene and many 
others in which LMNA was low or absent (Fig. 1). Based on these 
observation we choose for this study two neuroblastoma cell lines 
showing very different Lamin A/C expression levels. The Western 
Blotting reported in figure 2A shows the expression levels of 
Lamin A/C in five different neuroblastoma cell lines. We focused 
on the LAN-5 cells that do not express Lamin A/C and on the SH-
SY5Y cells that instead express Lamin A/C at the highest level.  
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Fig. 1. LMNA expression in neuroblastoma human biopsies. qRT-PCR 
analysis of the LMNA genes in 30 NB human biopsies. Data (mean + SD [n = 
3]) are reported as the ΔCt values normalized against the endogenous control. 
The ΔCt values are inversely correlated with the amount of the gene present in 
the sample. 
 
The different expression of Lamin A/C protein between the two 
cell lines was also evident studying the mRNA transcripts. In 
figure 2B are shown the level of expression of LMNA transcript in 
SH-SY5Y and LAN-5 cells as evaluated by qRT-PCR. A 
difference of more than 50% is observed between the two lines; 
while the levels of other two genes, the housekeeping TBP B and 
the structural LMNB1, are comparable between the two cell lines. 
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Fig. 2. Lamin A/C protein expression in NB cell lines. A) Representative blots 
of the Lamin A/C proteins in the indicated NB cell lines. GAPDH expression 
was used to normalize protein loading. The experiment was repeated three times 
with similar results. M, molecular weight markers. B) qRT-PCR analysis of the 
LMNA gene in LAN-5 cells (black) and SH-SY5Y cells (white); as control in 
the figure is also shown the expression of other two genes, the housekeeping 
TBP B and the structural LMNB1 genes. Data (mean + SD [n = 3]) are reported 
as the ΔCt values normalized against the endogenous control. The ΔCt values 
are inversely correlated with the amount of the gene present in the sample. C) 
qRT-PCR analysis of the not-spliced nascent transcripts of LMNA gene in 
LAN-5 cells (black) and SH-SY5Y cells (white). The data are reported as the 
level of mRNA relative to the endogenous control and are the mean + SD [n = 
3]. 
 
However, mature mRNA is subjected to stabilization processes 
that could mask the magnitude of the different transcriptional rate 
of Lamin A/C in SH-SY5Y and LAN-5 cells. Therefore, in order to 
measure more accurately the transcriptional rate of the LMNA 
gene we also analyzed the nascent, chromatin-associated, transcript 
of LMNA gene in both cell lines.  After extraction of the nuclear, 
not spliced, chromatin-associated RNA from both cell lines, the 
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level of LMNA nascent transcript was analyzed using two primer 
sets specific for the 5’ and 3’ of the coding region of the gene (Fig. 
2C). Specifically, the primers were designed to amplify regions 
lying across splicing junctions. (Contamination from genomic 
DNA are excluded by running qRT-PCR reactions with non-
reverse transcribed samples [RT-minus samples]).  
From this analysis we can conclude that the strong reduction of 
Lamin A/C protein level in LAN-5 cell line compared to SH-SY5Y 
is to be ascribed to a different transcriptional rate between the two 
cell lines, apparently due to a transcriptional repression of Lamin 
A/C in LAN-5 cells.  
 
Restoring Lamin A/C protein levels in LAN-5 cells by forced 
expression of LMNA gene. We then hypothesized that forcing the 
expression of LMNA gene in LAN-5 cells, which did not show any 
detectable level of the Lamin A/C protein, could be possible to 
restore a phenotype similar to that of the SH-SY5Y Lamin A/C 
expressing cells.  
We performed an infection of the LAN-5 cells using a 
lentiviral vector expressing LMNA gene (EX-Z3407-Lv105 
GeneCopeia). The analysis of the gene expression, performed after 
48 hours from cell infection, shows a strong over-expression of the 
LMNA gene already after 48 hours from cell infection (about 1200 
folds; Fig. 3A). By contrast, the analysis of protein expression 
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evaluated by western blot analysis, immunofluorescence and flow 
cytometry, showed that Lamin A/C was still completely 
undetectable (Fig. 3B, C and D). Increasing times of observation 
(up to 14 days after infection) under antibiotic selection did not 
modify the expression of Lamin A/C. Hence, it is likely that post-
transcriptional mechanisms may be involved in the down 
regulation of Lamin A/C protein in neuroblastoma LAN-5 cells.  
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Fig. 3. Forced LMNA gene expression in LAN-5 cells. A) The levels of 
LMNA mRNA in LAN-5 WT (white), Mock (grey) and LMNA+ (black) cells. 
The data are reported as the level of mRNA relative to the respective WT cells 
and are the mean + SD  [n = 3]. B) Representative blots of the Lamin A/C 
protein in LAN-5 Mock and LMNA+ cells. SH-SY5Y cells were used as control 
for Lamin A/C expression. GAPDH expression was used to normalize protein 
loading. The experiment was repeated three times showing similar results. M, 
molecular weight markers. C) Representative fluorescent images of SH-SY5Y 
and LAN-5 LMNA+ cells. Red, Lamin A/C immunostaining; blue, Hoechst. D) 
FACS analysis of the Lamin A/C fluorescence distribution in SH-SY5Y cells 
and LAN-5 LMNA+ cells. The experiment was repeated three times showing 
similar results. 
 
Putative miRNAs targeting LMNA transcripts. We therefore 
investigated whether the decreased level of expression of Lamin 
A/C in LAN-5 could be ascribed to a regulation by miRNAs. To 
test this hypothesis we performed an in silico analysis utilizing the 
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known databases miRWalk to identify putative miRNAs which can 
target LMNA gene. In the table 1. are reported the predicted 
miRNAs ordered by statistical significance. The table specified 
also the length of each miRNA and the targeting region.   We 
validated the results in silico in our cellular models by performing 
a miRNA expression profiling in LAN-5 and SH-SY5Y cells using 
TaqMan Human MicroRNA Arrays. A total of 768 miRNAs, 
present in the array, were analyzed in each cell line. The 
distribution of the expressed miRNAs is shown in a Venn diagram 
where a total of 417 (66 specific and 351 common) and of 395 (44 
specific and 351 common) miRNAs were found expressed in 
LAN-5 and SH-SY5Y cells, respectively (Fig. 4). We found 359 
and 337 miRNAs not expressed in SH-SY5Y and LAN-5 cells, 
respectively (293 not expressed at all in both cell lines). We 
identified a set of 202 out of the 351 common miRNAs 
differentially expressed at least 2-fold change between the two cell 
lines (99 in the LAN-5 and 103 in the SH-SY5Y cells); whereas 
149 miRNAs were filtered out by the threshold applied.  We then 
identified from the literature the most important genes codifying 
for proteins involved in the maturation pathway of Lamin A/C 
(such as ICMT1, ZMPSTE24) or structural nuclear proteins 
associated to Lamin A/C in forming the nuclear lamina. Using the 
Miranda tool we analyzed the miRNAs predicted to target the 
RNA sequence of each of these genes comparing the miRNAs 
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resulted from this analysis with those derived from the 
experimental PCR array and filtering in those miRNAs which were 
upregulated in LAN-5 cells. The table 2 shows only the miRNAs 
up regulated in the LAN-5 cells which do not express Lamin A/C. 
We focused on the unique miRNA predicted with a very 
significant p-value to target LMNA gene, hsa-miR-539-5p. 
 
Fig. 4. Functional analysis of miRNA target genes in LAN-5 and SH-SY5Y 
cell lines. Venn diagram of expressed miRNAs in SH-SY5Y and LAN-5 cells. 
The number represents the total miRNAs expressed in each line. 
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Table 1. Predicted miRNAs by miRWalk database targeting 
LMNA gene (NM_170707). 
 
 
 
 
MicroRNA Seed length Start  Position End Region Pvalue 
hsa-miR-485-5p 10 2719  2 2710 3 UTR 0.0010 
hsa-miR-539 10 2490  1 2481 3 UTR 0.0010 
hsa-miR-671-5p 10 2553  1 2544 3 UTR 0.0010 
hsa-miR-1200 10 2062  1 2053 CDS 0.0019 
hsa-let-7e 10 2190  2 2181 CDS 0.0019 
hsa-miR-1202 10 1191  2 1182 CDS 0.0019 
hsa-miR-760 10 2221  2 2212 CDS 0.0019 
hsa-miR-1322 10 2240  2 2231 CDS 0.0019 
hsa-miR-138 8 73  2 66 5 UTR 0.0038 
hsa-miR-615-5p 8 216  2 209 5 UTR 0.0038 
hsa-miR-657 8 245  1 238 5 UTR 0.0038 
hsa-miR-486-3p 8 223  1 216 5 UTR 0.0038 
hsa-miR-744 8 199  2 192 5 UTR 0.0038 
hsa-miR-138 8 73  2 66 5 UTR 0.0038 
hsa-miR-9-5p 9 2982  2 2974 3 UTR 0.0038 
hsa-miR-9-3 9 2544  1 2536 3 UTR 0.0038 
hsa-miR-576-3p 9 2528  2 2520 3 UTR 0.0038 
hsa-miR-1260 9 2931  2 2923 3 UTR 0.0038 
hsa-miR-92a-2-
5p 9 2836 
 
1 2828 3 UTR 0.0038 
hsa-miR-9-3 9 2982  2 2974 3 UTR 0.0038 
hsa-miR-9-1 9 2544  1 2536 3 UTR 0.0038 
hsa-miR-642 9 3052  2 3044 3 UTR 0.0038 
hsa-miR-9-1 9 2982  2 2974 3 UTR 0.0038 
hsa-miR-1182 9 524  2 516 CDS 0.0076 
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Table 2. Upregulated miRNAs in LAN-5 cells involved in the 
Lamin functions. 
hsa-miR LAN-5 SH-SY5Y Target
hsa-miR-539 1,8 7,8 LMNA
hsa-miR-543 5,5 27,2 LAP2
hsa-miR-410 4,5 11,2 LMNB1
hsa-miR-224 10,2 15,0
hsa-miR-329 10,3 20,1
hsa-miR-381 13,0 19,5
hsa-miR-186 1,1 2,7
hsa-miR-204 5,5 15,5
hsa-miR-134 5,0 12,4
hsa-miR-381 13,0 19,5 MAN1
hsa-miR-204 5,5 15,5
hsa-miR-134 5,0 12,4
hsa-miR-329 10,3 20,1
hsa-miR-410 4,5 11,2
hsa-miR-495 4,6 10,5
hsa-miR-873 12,2 15,4
hsa-miR-381 13,0 19,5 ZMPSTE24
hsa-miR-379 4,6 10,3
hsa-miR-495 4,6 10,5
hsa-miR-488 10,8 12,5
hsa-miR-182 9,8 16,2
hsa-miR-224 10,2 15,0
hsa-miR-433 3,8 19,5
hsa-miR-494 4,6 11,7
hsa-miR-365 7,3 9,8
hsa-miR-488 10,8 12,5 ICMT1
hsa-miR-495 4,6 10,5
hsa-miR-410 4,5 11,2
hsa-miR-186 1,1 2,7
hsa-miR-410 4,5 11,2 CDK1
hsa-miR-495 4,6 10,5
hsa-miR-329 10,3 20,1
hsa-miR-143 8,0 4,8
hsa-miR-543 5,5 27,2
hsa-miR-181a 7,2 5,7
hsa-miR-181c 16,1 12,6
hsa-miR-146a 10,7 9,81
hsa-miR-146b-5p 16,9 14,48
hsa-miR-374a 5,1 3,9 PKC alpha
hsa-miR-374b 3,6 2,9
hsa-miR-873 12,2 15,4
hsa-miR-186 1,1 2,7 SUMO1
hsa-miR-495 4,6 10,5
hsa-miR-133a 4,9 8,7
hsa-miR-133b 11,6 15,2
∆Ct
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Mimicking or inhibiting hsa-miR-539-5p in neuroblastoma 
cells. By real time PCR we first verified the expression levels of 
the hsa-miR-539-5p in both SH-SY5Y and LAN-5 cell lines and 
the result confirms that this miRNA is really overexpressed in 
LAN-5 cells by about 50% (Fig. 5A). To investigate whether hsa-
miR-539-5p could target LMNA gene we overexpressed or 
inhibited this miRNA in SH-SY5Y and LAN-5 cells, respectively. 
The transfection of SH-SY5Y with the miR-539 mimic resulted in 
approximately 15000-fold increased expression of the miRNA, 
while the transfection of LAN-5 with the miR-539 inhibitor 
resulted in a total repression of the miRNA expression (Fig. 5B). 
However, the expression of the protein was not affected by these 
treatments in both cell lines as shown in the western blot analysis 
(Fig. 5C). The results obtained allowed us to exclude miR-539-5p 
as a possible regulator of the expression of Lamin A/C.  
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Fig. 5. Modulation of hsa-miR-539-5p. A) The levels of hsa-miR-539-5p in 
SH-SY5Y cells (white) and in LAN-5 cells (black). The data are reported as the 
ΔCt values normalized against the endogenous control. The ΔCt values are 
inversely correlated with the amount of the gene present in the sample. B) The 
levels of the hsa-mir-539-5p in mimic negative control (white) and miRNA 
mimic (black) cells at 24 after transfection in SH-SY5Y cells; and levels of the 
hsa-mir-539-5p in inhibitor negative control (white) and miRNA inhibitor 
(black) cells at 24 after transfection in LAN-5 cells. The data are reported as the 
level of miRNAs relative to the respective miRNAs negative control cells and 
are the mean + SD [n = 3]. C) Representative western blots of the indicated 
proteins in mimic negative control (CTR) and miR-539-5p mimic cells at 24 
after transfection in SH-SY5Y cells and in inhibitor negative control (CTR) and 
mir-539-5p inhibitor at 24 after transfection in LAN-5 cells. GAPDH expression 
was used to normalise protein loading. The experiment was repeated three times 
with similar results. M, molecular weight markers.  
 
 
Study of chromatin organization on LMNA promoter. The 
ChIP technique is used to study interactions between specific 
proteins (e.g. transcription factors, transcriptional co-regulators 
and/or histones) and genomic DNA region (e.g. promoters, 
enhancers or coding regions of specific genes). Post translational 
modifications of histones represent an epigenetic mechanism of 
regulation of gene expression, indeed different combinations of 
histone modifications at promoters and enhancers lead to specific 
functional outcomes. We carried out ChIP experiments to analyze 
the enrichment of specific post-translational histone modifications 
on LMNA promoter, namely trimethylation of lysine 4 oh histone 
H3 (H3K4me3), and trimethylation of lysine 27 (H3K27me3) 
associated with transcriptional activation and transcriptional 
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repression, respectively. The enrichment of these two histone 
marks was measured both in SH-SY5Y and LAN-5 cells at two 
different regions of LMNA promoter, one proximal to the 
transcription start site (TSS) and a second one upstream of TSS. 
The LMNA promoter showed a similar chromatin landscape in the 
two cell lines, specifically a strong H3K4me3 enrichment, whereas 
no significant enrichment for H3K27me3 were observed, 
indicating that LMNA promoter display, both in SH-SY5Y and 
LAN-5 cells, the same open chromatin organization, permissive for 
transcriptional activation (Fig. 6 A and B).  
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Fig. 6. ChIP analysis of histone modifications on LMNA promoter. A) ChIP-
qPCR analysis of H3K4me3 at two different regions of the LMNA promoter and 
at ActB promoter in SH-SY5Y and LAN-5 cells. B) ChIP-qPCR analysis of 
H3K27me3 at two different regions of the LMNA promoter and at GAPDH, 
MyH6 promoters in SH-SY5Y and LAN-5 cells. The data have been normalized 
to input. Error bars, of three independent experiments. 
 
Study of Sp1 recruitment on LMNA promoter. The similar 
enrichment pattern of histone modifications associated with gene 
activation or repression (specifically H3K4me3 and H3K27me3) 
on LMNA promoter in SH-SY5Y and LAN-5 cells does not 
explain the different transcription rate observed in these two cell 
lines.  
We decided to analyze the recruitment of Sp1 transcription 
factor, a member of the Sp transcription factor family, on LMNA 
promoter. First, we analyzed the constitutive expression of Sp1 
protein in SH-SY5Y and LAN5 cells. The western blot analysis in 
figure 7A shows that Sp1 is expressed at similar levels in the two 
cell lines. ChIP experiments were performed on chromatin derived 
from both cell lines and demonstrate a lower recruitment of Sp1 on 
the LMNA promoter in LAN-5 cells (Fig. 7B), thus correlating to 
the reduced transcription of LMNA in these cells. Presumably, the 
reduced recruitment of Sp1 transcription factor determines a lower 
recruitment of basal transcriptional machinery on LMNA promoter 
in LAN-5 cells. 
Ilaria Iannetti 
Pag 68  
This latter hypothesis was confirmed by analyzing the level of 
trimethylation of Lys36 of histone H3 along the coding region of 
LMNA gene; this histone modification is catalyzed by a histone 
methyltransferase travelling with RNA polymerase II during 
elongation, thus representing a mark of of actively transcribed 
genes. The chromatin immunoprecipitation experiments 
demonstrate that this mark is lower in LAN-5 cells, thus 
correlating to the reduced transcription rate of LMNA gene in this 
cell line (Fig. 7C). 
Collectively, we found that, despite of a permissive chromatin 
configuration, the transcription factor Sp1 and, consequently, the 
Polymerase II transcriptional machinery, are not recruited on 
LMNA promoter of LAN-5 cells.  
Localized DNA hypermethylation of promoter regions leading 
to transcriptional repression were found to be a common feature of 
many cancers.  Ongoing experiments aim at analyzing DNA 
methylation of LMNA locus in SH-SY5Y and LAN-5 cells in 
order to verify whether a different pattern of DNA methylation 
could be responsible for the different regulation of LMNA 
expression.  
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Fig. 7. Study of interaction of LMNA promoter with the Sp1 TF by ChIP. 
A) Western blot analysis and relative densitometry of Sp1 protein in HeLa, SH-
SY5Y and LAN-5 cells. GAPDH expression was used to normalize protein 
loading. The experiment was repeated three times showing similar results. M, 
molecular weight markers. B) ChIP-qPCR analysis of Sp1 binding to LMNA 
promoter in SH-SY5Y and LAN-5 cells. The data shows the fold over Mock. 
Error bars, of three independent experiments. C) ChIP analysis of H3K36me3 
modifications on LMNA coding sequence in SH-SY5Y and LAN-5 cells. The 
data have been normalized to input. Error bars, of three independent 
experiments. 
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4 DISCUSSION 
 
A-type lamins are essential components of the nuclear lamina. 
Together with B-type lamins they form the network located in the 
inner side of the nuclear membrane. Lamin A/C have been 
suggested as a biomarker for various types of cancer (Foster et al., 
2010). Lamin A/C are absent in embryonic stem cells and some 
adult stem cell types but are expressed in the majority of cell types 
in adults, thereby suggesting that their expression is an indicator of 
differentiation (Lin et al., 1997). Mutation in LMNA gene causes 
the Emery-Dreifuss muscular dystrophy (EDMD) (Bonne et al., 
1999), from 1999 more than 450 diseases have been associated 
with mutations of LMNA gene, and are collectively referred to the 
term Laminopathies. These disorders include Hutchiston-Gilford 
progeria syndrome (HGPS), dilated cardiomyopathy with 
conduction defect (DCM-CD), the familiar partial dystrophy 
Dunningan (FPLD), the Charcot-Marie Tooth (CMTS) and many 
others. The most studied among these diseases is HGPS, in this 
case a mutation leading to aberrant splicing of prelamin A 
transcripts, the protein Lamin A/C lacks 150 nucleotides (AΔ50) 
and leads to the production of progerin, a major, internally 
truncated prelamin A, which is processing-incompetent and 
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accumulates in the nuclei of the cells, exerting multiple toxic 
effects. Other aberrant transcripts as prelamin AΔ35 and prelamin 
AΔ90 have been involved in the pathophysiology of specific 
progeroid syndromes (Hisama et al. 2011). As concern the 
relationship between lamins and cancer even though contrasting 
results are present in literature in general, most malignant tumors 
present decreased levels of Lamin A/C.  Loss of lamin A/C 
expression has been reported for colon cancer (Willis et al., 2008), 
lung cancer (Machiels et al., 1995), prostate cancer (Debes et al., 
2005), gastric cancer, breast cancer (Callinice et al., 2011), 
leukemia and lymphoma (Agrelo et al., 2005). A down regulation 
of Lamin A/C could result in increased nuclear deformability 
thereby facilitating transit of cells through capillaries and favoring 
cell invasion (Foran et al., 2006). During my PhD I studied some 
of the mechanisms possibly underlying the reduced expression of 
Lamin A/C protein in a NB cellular model, the LAN-5 cells. In the 
LAN-5 cells there is a complete loss of Lamin A/C protein levels 
compared to the control SH-SY5Y cells, which instead presented 
high levels of the protein. The decreased protein levels in LAN-5 
cells were accompanied by a reduced transcription rate of the 
LMNA gene (about 3-folds) with respect to the SH-SY5Y control 
cells. Moreover, the analysis of the nuclear, not spliced, chromatin-
associated RNA confirm the reduced transcriptional rate in the 
LAN-5 cells. Our first hypothesis was that a transcriptional 
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regulation mechanism is responsible of the downregulation of 
LMNA gene. In order to study whether an overexpression of 
LMNA gene could modify the biological behavior in the LAN-5 
cells we decided to force the expression of LMNA gene in these 
cells by using a lentiviral vector carrying an LMNA construct. 
Even if the transcripts of the LMNA gene were significantly up 
regulated by about 1200-folds after infection, the protein was still 
undetectable.  Hence, it is likely that not only a transcriptional but 
also a post-transcriptional mechanism could be involved in the 
down regulation of Lamin A/C protein in LAN-5 cells. As first 
mechanism, we investigated the mRNA targeting by microRNAs 
(miRNAs). miRNAs have a strong influence on gene expression, 
and they allow simultaneous regulation of multiple components of 
the signaling network in normal development, differentiation, 
growth and in human diseases such as cancer (Jansson et al., 
2012). The in Silico analysis I performed using the database 
miRWalk allowed identifying several putative miRNAs, which 
could target LMNA gene. The unique miRNA predicted with a 
very significant p-value to target LMNA gene was the hsa-miR-
539. In order to verify the possibility to restore Lamin A/C 
expression in LAN-5 cells we inhibited hsa-miR-539 in these cells 
using the mirVana reagents. Simultaneously, in the SH-SY5Y 
control cells we overexpressed the same miRNA in order to down 
regulate LMNA gene. The modulation of hsa-miR-539 in both cell 
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lines did not result in any modification of the Lamin A/C 
expression thus demonstrating that miR-539 is not involved in the 
knockdown of the Lamin A/C protein. However, we cannot 
exclude that other miRNAs targeting other components of nuclear 
lamina could be involved in the Lamin A/C regulation.  
We also studied whether epigenetic mechanisms such as histone 
modifications of LMNA promoter could be involved. Histone 
modifications in the cancer landscape are markers of function and 
chromatin state. Aberrant histone methylation frequently occurs in 
tumor development and progression. Multiple studies have 
identified that histone lysine methyltransferases regulate gene 
transcription through the methylation of histones, which affects 
cell proliferation and differentiation, cell migration and invasion, 
and other biological characteristics. Histones have variant lysine 
sites for different levels of methylation, catalyzed by different 
lysine methyltransferases, which have numerous effects on human 
cancers. For example the knockdown of SETDB1 (a specific 
methyltranspherase for lysine 9 of Histone 3) reduced lung cancer 
cell growth in vitro and in vivo, and overexpression of SETDB1 
promoted cancer cell invasiveness (Schultz et al., 2002). Another 
example is the methyltrasferase zeste protein-2 (EZH2) specific for 
lysine 27 of Histone 3 (H3K27). Enhancer of EZH2, as a catalytic 
component of the polycomb repressive complex 2, catalyzes 
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histone H3K27 tri-methylation. To date, >300 studies have 
reported a close correlation between EZH2 and 46 types of human 
cancer. EZH2 is commonly overexpressed in the majority of 
common cancers, and high EZH2 expression is a prognostic 
indicator of poor survival. In breast cancer, downregulation of 
EZH2 blocks the cell cycle, and suppresses cell growth and 
survival (Jansen et al., 2012).  MYND domain-containing protein 
3 (SMYD3) is other methyltransferases specific for lysine 4 of 
histone 3 (H3K4). In colorectal cancer and esophageal squamous 
cell carcinoma, knockdown of SMYD3 impairs cell proliferation 
(Peserico et al., 2015; Dong et al., 2014). In our models the study 
of two histone markers, such as H3K4me3 and H3K27me3, on two 
different region of LMNA promoter, demonstrated that LMNA 
promoter has the same permissive chromatin organization in both 
LAN-5 and SH-SY5Y cell lines. This indicates that a 
transcriptional control mechanism is not mediated by histone 
modifications.  
We further investigated the effect of the Sp transcription factors 
(TFs) family on the LMNA promoter. We considered the Sp1 TF 
which is the one recruiting the transcriptional complex at the 
LMNA promoter.  Sp1 was considered a general TF required for 
transcription of a large number of ‘housekeeping genes’ (Black et 
al., 2001). However, recently a study has indicated that many of 
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these housekeeping genes are crucial in tumorigenesis and cancer 
progression because it can activate and suppress the expression of 
a number of essential oncogenes and tumor suppressors (Beishline 
et al., 2015). Consequently, Sp1 has been demonstrated to be 
important in tumor progression, including cell proliferation, 
angiogenesis, differentiation, apoptosis, migration and invasion, 
revealing it as an ideal target for cancer treatment (Sankpal et al., 
2011). ChIP data shows that there is a lower recruitment of Sp1 TF 
on the LMNA promoter in LAN-5 cells with respect to SH-SY5Y 
cells. Hence, the transcription of LMNA gene could be reduced by 
this mechanism.  
In conclusion, we demonstrated that the main regulation 
mechanism involved in the down-regulation of LMNA gene in NB 
cells is a transcriptional mechanism. We cannot exclude that also a 
post-translational regulation mechanism could mediate the strong 
knock-down of Lamin A/C observed in LAN-5 cells. Possibly 
protein degradation mediated by proteasome could occur. A 
mechanism that needs to be investigated in detail. The 26S 
proteasome is an essential protein complex responsible for 
degrading the majority of cellular proteins in eukaryotes. This 
mechanism is complex and it is regulated at several levels by 
multiple mechanisms, ranging from transcriptional control to post-
translational modifications of proteasome subunits. An impaired 
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proteasome system often underlies neurodegenerative diseases and 
the aging process (López-Otín et al., 2013). On the other hand, the 
rapid growth of cancer cells is often dependent on elevated 
proteasome activity in many types of tumors such as myeloma and 
certain solid cancer (Hoeller et al., 2009; Guo et al., 2016). For 
example, it is known that proteasome inhibition results in reduction 
of cancer progression in cervical cancer cells (Rastogi et al., 2015). 
Moreover, Lamin A/C proteins are target for serine/threonine 
(SER/THR) kinases that are overexpressed in cancer cells (e.g. p-
AKT) (Naeem et al., 2015). As matter of fact, p-Akt is viewed as a 
promising therapeutic target in cancer pathology and therapy: 
drugs that can inhibit SER/THR kinase activities of p-AKT may 
also restore Lamin A/C.  
Reduction of Lamin A/C in cancer cells may also be an important 
mechanism producing aneuploidy and chromosomal numerical 
instability hypothesizing that the loss of Lamin A/C, associated 
with additional oncogenic mutations, could impair cell growth and 
trigger tumor progression (Callinice et al., 2011). Cells bearing 
mutations in LMNA gene or lacking Lamin A/C display abnormal 
nuclear morphology, defective cell cycle kinetics, polyploidy, loss 
of heterochromatin organization and chromosomal aberration,  all 
of which are hallmark for dedifferentiated cancer cells. 
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5 MATERIALS AND METHODS 
 
Human NB biopsy RNA extraction and real‐time 
RT‐PCR 
 
       Total RNA was extracted from thirty frozen biopsies of human 
newly diagnosed NBs obtained from Department of Pediatrics and 
Infantile Neuropsychiatry of Sapienza University, Rome using 
TRIzol reagent (Life Technologies) according to the 
manufacturer’s instructions. RNA was reverse-transcribed, and 
real-time PCR performed as described above. Institutional written 
informed consent was obtained from the patient’s parents or legal 
guardians according to the local institutional guidelines. 
Cell line maintenance  
The SH-SY5Y NB cell line was purchased from ATCC. These 
cells were seeded in adherent conditions in the presence of 1:1 
mixture of Eagle's Minimum Essential Medium and F12 medium 
(Gibco) supplemented with 10% FBS (Hyclone), 2 mM L-
glutamine, 0.5% non-essential amino acids, 0.5% sodium pyruvate 
and 1% penicillin and streptomycin. The LAN-5 Neuroblastoma 
(NB) cell line (a gift from Dr. Doriana Fruci) was grown in RPMI-
1640 medium (Gibco) supplemented with 10% FBS (Hyclone), 2 
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mML-glutamine and 1% penicillin/streptomycin in a fully 
humidified incubator containing 5% CO2 at 37°C.  
Western blot analysis 
SH-SY5Y and LAN-5 NB monolayers were washed twice 
with 1X PBS and then incubated for 1 min in urea buffer (8M urea, 
100mM NaH2PO4 and 10mM Tris pH 8), harvested and briefly 
sonicated. The proteins were run on a pre-cast 
polyacrylamide NuPAGE 10% Bis-Tris gel and NuPAGE 4-12% 
Bis-Tris gel (Life Technologies). The resolved proteins were 
blotted overnight onto nitrocellulose membranes, then blocked in 
1X PBS containing 5% non-fat milk for at least 1 h. The blots were 
incubated with the following primary anti-human antibodies: 
monoclonal anti-Lamin A/C (clone JOL2; Chemicon 
International); monoclonal anti-Sp1 (ab13370, Abcam) 
monoclonal anti-GAPDH (6C5; Millipore). After washing, the 
membranes were then incubated for 45 min with the 
secondary donkey anti-mouse or anti-rabbit antibody IRdye800 
(LI-COR). After further washing, membranes were then analysed 
with a Licor Odyssey Infrared Image System in the 800 nm 
channel. Blot scan resolution was 150 d.p.i. 
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Total RNA preparation 
Total RNA was isolated using a Total RNA purification kit 
(Norgen Biotek, Thorold, ON, Canada). RNA quantity was 
determined by measuring absorbance at 260 nm using a NanoDrop 
UV-VIS spectrophotometer. The quality and integrity of each 
sample was confirmed using a BioAnalyzer 2100 (Agilent RNA 
6000 Nanokit); samples with an RNA Integrity Number (RIN) 
index lower than 8.0 were discarded. 
Real‐time RT‐PCR analysis 
RNA (250 ng) was retro-transcribed with High-Capacity 
cDNA Reverse Transcription Kit (Applied Biosystem) according 
to the manufacturer’s instructions. Equal amount of cDNA was 
then subjected to real time PCR analysis with an Applied 
Biosystems 7500HT thermal cycler, using the SensiMix SYBR Kit 
(Bioline) and the following specific primers at a concentration of 
200 nM. Each experiment was performed in triplicate. The 
expression data were normalized using the Ct values of GAPDH 
and TBP. 
Primer Unigene Forward Sequence Reverse Sequence 
LMNA Rn.44161 GAGCAAAGTGCG
TGAGGAGT 
TCCCCCTCCTTC
TTGGTATT 
GAPDH Hs.544577 AGCCACATCGCTC
AGACA 
GCCCAATACGA
CCAAATCC 
TBP Hs.590872 GAACATCATGGA
TCAGAACAACA 
ATAGGGATTCC
GGGAGTCAT 
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Cell infection 
 
Proliferating LAN-5 cells were transfected with a plasmid 
carrying the LMNA construct driven by the CMV promoter (pEZ-
Lv105, GeneCopoeia) using Lipofectamine2000 (Life 
Technologies) according to the manufacturer’s instructions. We 
used 2.5 µg of DNA per sample. LMNA expression was monitored 
by checking the simultaneous coexpression of the EmGFP reporter 
gene by fluorescence microscopy. 
PCR Array 
RNA was reverse transcribed using TaqMan MicroRNA 
Reverse Transcription kit (Applied Biosystems). cDNA was 
preamplified using TaqManPreAmp Master Mix (Applied 
Biosystems). qRT-PCR was performed with an Applied 
Biosystem7500HT thermal cycler using TaqMan human 
microRNA array (TaqMan Human microRNA Array A #4398977 
and B v3.0 #442812; Applied Biosystems) according to 
manufacturer’s instructions. The downstream analysis filtered out 
miRNAs not detected in both cell lines (293), whereas those 
specifically expressed either in LAN-5 or in SH-SY5Y were 
considered and reported as cell line-specific. Data were then 
normalized calculating the ∆Ct value for single miRNA against the 
average of the specific controls for each card according to 
manufacturer's instructions. Differential expression analysis was 
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performed according to ∆∆Ct method and only RQ ≥ 2 fold-change 
were considered for further analysis. miRNAs clusters were 
generated through the DIANA web tool mirPath v2.0 using 
miRBase MIMAT IDs (Release 21) remapped to the newest human 
genome assembly (GRCh38) to avoid duplicate entries present in 
the previous release. Uniquely targets reported in TarBase database 
v7.0 were included in the clustering, predicted targets were not 
taken into account. False Discovery Rate (FDR) correction was 
applied to the original p-value and only clusters with corrected p-
values < 0.05 were shown. 
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miRNA Assays 
Equal amounts of RNA were reverse transcribed with the 
TaqMan® MicroRNA Reverse Transcription Kit (Applied 
Biosystems) according to the manufacturer’s instructions, with a 
custom 1X RT primer pool (hsa-miR-539-5p ID 001286; has-miR-
16ID 000391; U6 snRNA ID 001973). Real time PCR analysis was 
performed with an Applied Biosystems 7500HT thermal cycler 
using 20X Individual TaqMan® MicroRNA Assays. 
 
Hsa-miR-539 inhibitor and mimic 
LAN-5 and SH-SY5Y cells were seeded at a density of 3x105 
cells in 35 mm dishes. After 24 h, the cells were transfected 
overnight in the presence of 10% FBS with mirVana miRNA 
inhibitor, miRNA mimic or the respective negative controls. 
Lipofectamine2000 (Life Technologies) was used as the 
transfection reagent, according to the manufacturer’s instructions. 
We transfected the has-miR-539 inhibitor (MH11336, Ambion) 
and the mimic (MC11336, Ambion) at a final concentration of 
approximately 30 nM. The mirVana miRNA inhibitor and mimic 
negative control were used at the same final concentration of 30 
nM. Samples were harvested after 24 h from transfection to 
perform mRNA expression analysis.  
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Chromatin Immunoprecipitation (ChIP) 
 
Cells were grown up to 80% of confluence before harvesting. 
For chromatin crosslinking formaldehyde (Sigma: F8775) was 
added directly to culture medium to a  final concentration of 1% 
and incubated for 10 minutes at room temperature; then, 
formaldehyde wasquenched by addingTris-HCl, pH 7.5 (0.125M 
final concentration) for 5 minutes and cells were washed 3 times 
with ice-cold PBS. Fixed cells were collectedin cold PBS by 
scraping and spinned down by centrifugation. Fixed cell pellets can 
be flash frozen and stored at −80°C or directly used to prepare 
nuclear extracts.  
Nuclear extracts were prepared as follows: 
 Lysis of cytoplasmatic membrane by LB1 buffer (50 
mMHepes-KOH pH 7.5,  140 mMNaCl, 1 mM EDTA, 
10% glycerol, 0.5% NP-40, 0.25% Triton X-100). Keep on 
ice for 10 minutes and spin down the nuclei. 
 Wash of nuclei and removal of detergents by LB2 buffer 
(10 mMTris-HCl, pH 8.0, 200 mMNaCl, 1 mM EDTA, 
0.5mM EGTA).Rock gently at room temperature for 10 
minutes and spin down the nuclei. 
 Lysis of nuclei by LB3 buffer (10 mMTris-HCl, pH 8.0 , 
100 mMNaCl, 1 mM EDTA, 0.5 mM EGTA, 0.1% Na-
Deoxycholate, 0.5% N-lauroylsarcosine)  
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All lysis buffer were supplemented with protease inhibitors 
(Protease complete Inhibitor Cocktail - Roche: 04693132001). 
Nuclear extracts were sonicated using an ultrasonic Bioruptor 
sonicator to shear chromatin to an average fragment size of 300-
700 bp; DNA fragments were extracted starting from a small 
amount of sonicated chromatin and checked on agarose gel.  
The sonicated chromatin was used for immunoprecipitation 
with 2-5 μg of the antibody of interest previously coupled to 
protein G (Life Technologies #10004D), overnight with constant 
rotation at 4°C. The antibodies used for the experiments described 
in the results are reported below. The immune-complexes were 
then sequentially washed 6 times with cold washing buffer (50 
mMHepes-KOH, 500 mMLiCl, 1 mM EDTA, 1% NP-40, 0.7% 
Na-Deoxycholate) and once with TE 50mMNaCl, and then 
extracted with Elution Buffer (10mM Tris-HCl, pH 8.0, 5mM 
EDTA, 300mM NaCl, 0.5% SDS). Protein-associated DNA 
fragments were recovered by reversion of crosslinking (65°C 
overnight) followed by DNA extraction with SPRI cleanup beads 
(AMPureBeckman #A63881). ChIP-DNA was then quantified by 
Quant-IT Picogreen dsDNA Assay kit (#P11496) prior to 
proceeding to qPCR analysis. Primers used for ChIP analysis by 
qPCR are listed below. 
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Antibodies list  
 Anti-trimethyl-Histone H3 (Lys4) (Anti-H3K4me3) - Abcam 
ab-8580 
 Anti-trimethyl-Histone H3 (Lys27) (Anti-H3K27me3) - 
Millipore 07-449 
 Anti-Sp1 - Abcam 13370   
 Anti-trimethyl-Histone H3 (Lys36) (Anti-H3K36me3) - Abcam 
ab-9050 
 
Human ChIP primers 
Target 
Name 
Primer 
Name 
Forward sequence Reverse sequence 
Lamin 
A/C 
LMNA 
TSS 
TCGGACCTGGGAG
TCTCTAG 
AAGAGTTTGAGCG
CTGGAAG 
Lamin 
A/C 
LMNA 
UPS 
TCCTAGTTCTCCA
AAGCCCC 
TTTCCCTTCCACCA
CCTCTC 
Lamin 
A/C 
LMNA 
CDS 5’ 
GCGTGAGGAGTTT
AAGGAGC 
GCAAAGTTATCGG
CCTCCAG 
Actin 
Beta 
ActB CCCAACACCACAC
TCTACCT 
CTTGCCGACTTCA
GAGCAAC 
Myosin 
heavy 
chain 6 
MyH6 TTGGGGAACAGAA
GGAGACC 
CCAGGGAAGGGAT
CTGTTGT 
GAPDH GAPDH CCAATCTCAGTCC CCCTACTTTCTCCC
Dottorato di ricerca in Genetica e Biologia Molecolare 
 Pag. 87  
CTTCCCC CGCTTT 
GAPDH GAPDH 
CDS5’ 
CACATCGCTCAGA
CACCATG 
CATACGACTGCAA
AGACCCG 
STAT1 STAT1 TGTAGGTGTGAAG
CCCAGAG 
GGCTTCTCCTAAA
CGTGTG 
 
Nascent Transcripts 
 
Cells were grown up to 80% of confluence before harvesting. 
The nuclei were prepared in a lysis buffer (50mM Tris-HCl pH 
8.0; 0.2mM EDTA pH 8.0; 1% NP-40; 10% glycerol), and purified 
by sucrose cushion (1.5mM Hepes pH 7.9; 0.5mM EDTA; 15 
mMNaCl; 60 mMKCl;10% glycerol; 0.9 M sucrose). The nuclei 
were then resuspended in nuclear resuspension buffer (0.5mM 
EDTA; 20mM Tris-HCl pH 7.5; 75 mMNaCl; 50% glycerol; 100 
µg/ml Yeast tRNA), before lysis with nuclear lysis buffer (20 
mMHepes pH 7.6; 0.2mM EDTA; 0.3 M NaCl; 1% NP-40; 7.5 
mMMgCl2; 1 M Urea; 100 µg/ml Yeast tRNA. All buffers were 
supplemented withDTT (1mM), PMSF (0.5 mM), spermine 
(0.15mM) and spermidine(0.5mM).RNA was then isolated using a 
Total RNA purification kit (NorgenBiotek#48300) or standard 
Trizol protocol (Invitrogen). RNA concentration was quantified by 
NanoDrop measurement of the absorbance at 260 nm.0.5 µg of 
RNA was used for reverse transcription with standard protocol. 
cDNA was amplified by qPCR with primers specific for pre-
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mRNA (designed to amplify either intronic regions, or regions 
lying across splicing junctions). Contamination from genomic 
DNA are excluded by running qPCR reactions with non-reverse 
transcribed samples (RT-minus samples).Primers used for nascent 
transcripts analysis by qPCR are listed below. 
 
Human nascent transcripts primers 
Target 
Name 
Primer 
name 
Forward sequence Reverse sequence 
Lamin 
A/C 
LMNA 
CDS 5’ 
GCGTGAGGAGTTT
AAGGAGC 
GCAAAGTTATCG
GCCTCCAG 
Lamin 
A/C 
LMNA 
CDS 3’ 
AATCTGGTCACCC
GCTCCTA 
TCCTACCCCTCGA
TGACCA 
TBP TBP CDS AGTTCTGGGATTG
TACCGCA 
GTGCCACTCCCTC
CCTTAAT 
 
 
Statistical analysis 
Student’s t test (unpaired, two-tailed) was used for statistical 
comparison between two groups. If there were more than two 
groups, we used the one-way ANOVA test. 
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APPENDIX 1 
 
TaqMan Human microRNA Array A v. 3.0 (Applied 
Biosystems). 
 
 
 
 
LAN-5 
 
SH-SY5Y 
 Pos Detector Ct ∆Ct Ct ∆Ct 
A1 hsa-let-7a-4373169 23,10 6,36 18,70 2,12 
A2 hsa-let-7c-4373167 28,06 11,32 20,93 4,36 
A3 hsa-let-7d-4395394 24,49 7,75 19,89 3,32 
A4 hsa-let-7e-4395517 20,91 4,17 16,96 0,39 
A5 hsa-let-7f-4373164 27,61 10,87 23,85 7,28 
A6 hsa-let-7g-4395393 22,41 5,67 18,96 2,39 
A7 hsa-miR-1-4395333 30,14 13,40 31,71 15,14 
A8 hsa-miR-9-4373285 19,18 2,44 18,12 1,55 
A9 hsa-miR-10a-4373153 29,35 12,61 26,02 9,44 
A10 hsa-miR-10b-4395329 21,56 4,82 18,53 1,96 
A11 MammU6-4395470 17,08 
 
17,11 
 A12 MammU6-4395470 17,34 
 
17,11 
 A13 hsa-miR-15a-4373123 23,32 6,58 23,54 6,97 
A14 hsa-miR-15b-4373122 19,63 2,89 18,16 1,59 
A15 hsa-miR-16-4373121 17,39 0,65 16,90 0,33 
A16 hsa-miR-17-4395419 14,20 -2,54 14,23 -2,34 
A17 hsa-miR-18a-4395533 19,32 2,58 19,77 3,20 
A18 hsa-miR-18b-4395328 24,86 8,12 25,24 8,67 
A19 hsa-miR-19a-4373099 19,11 2,37 20,38 3,81 
A20 hsa-miR-19b-4373098 15,39 -1,35 15,68 -0,90 
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A21 hsa-miR-20a-4373286 15,46 -1,28 15,23 -1,34 
A22 hsa-miR-20b-4373263 17,59 0,85 17,19 0,62 
A23 hsa-miR-21-4373090 24,35 7,61 20,27 3,70 
A24 hsa-miR-22-4373079 29,24 12,50 26,61 10,04 
B1 hsa-miR-23a-4373074 Undetermined 
 
34,02 17,44 
B2 hsa-miR-23b-4373073 23,86 7,12 24,22 7,65 
B3 hsa-miR-24-4373072 15,78 -0,96 15,10 -1,47 
B4 hsa-miR-25-4373071 19,10 2,36 17,66 1,09 
B5 hsa-miR-26a-4395166 20,28 3,54 18,49 1,92 
B6 hsa-miR-26b-4395167 23,09 6,35 20,85 4,28 
B7 hsa-miR-27a-4373287 23,05 6,31 20,49 3,92 
B8 hsa-miR-27b-4373068 21,21 4,47 19,75 3,18 
B9 hsa-miR-28-3p-4395557 21,74 5,00 23,04 6,47 
B10 hsa-miR-28-5p-4373067 24,48 7,74 23,82 7,25 
B11 MammU6-4395470 17,38 
 
17,24 
 B12 MammU6-4395470 16,84 
 
16,74 
 B13 hsa-miR-29a-4395223 22,68 5,94 21,42 4,85 
B14 hsa-miR-29b-4373288 30,77 14,03 28,27 11,69 
B15 hsa-miR-29c-4395171 27,63 10,89 25,59 9,02 
B16 hsa-miR-30b-4373290 18,59 1,85 18,03 1,46 
B17 hsa-miR-30c-4373060 17,80 1,06 17,21 0,64 
B18 hsa-miR-31-4395390 Undetermined 
 
Undetermined 
 B19 hsa-miR-32-4395220 28,88 12,14 29,38 12,81 
B20 hsa-miR-33b-4395196 Undetermined 
 
Undetermined 
 B21 hsa-miR-34a-4395168 25,55 8,81 18,87 2,29 
B22 hsa-miR-34c-5p-4373036 32,25 15,51 26,86 10,29 
B23 hsa-miR-92a-4395169 16,22 -0,52 16,51 -0,06 
B24 hsa-miR-93-4373302 17,00 0,26 15,51 -1,07 
C1 hsa-miR-95-4373011 24,35 7,61 22,42 5,85 
C2 hsa-miR-96-4373372 30,07 13,33 Undetermined 
 C3 hsa-miR-98-4373009 30,31 13,57 25,87 9,30 
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C4 hsa-miR-99a-4373008 27,64 10,90 21,96 5,38 
C5 hsa-miR-99b-4373007 20,73 3,99 20,03 3,46 
C6 hsa-miR-100-4373160 26,83 10,09 21,32 4,75 
C7 hsa-miR-101-4395364 26,13 9,39 24,61 8,04 
C8 hsa-miR-103-4373158 20,29 3,55 19,68 3,10 
C9 hsa-miR-105-4395278 26,86 10,12 27,04 10,47 
C10 hsa-miR-106a-4395280 14,15 -2,59 14,17 -2,41 
C11 RNU44-4373384 16,70 
 
16,34 
 C12 hsa-miR-106b-4373155 18,86 2,12 17,02 0,45 
C13 hsa-miR-107-4373154 25,04 8,30 24,06 7,48 
C14 hsa-miR-122-4395356 Undetermined 
 
37,38 20,81 
C15 hsa-miR-124-4373295 27,56 10,82 27,64 11,07 
C16 hsa-miR-125a-3p-4395310 27,25 10,51 27,23 10,66 
C17 hsa-miR-125a-5p-4395309 17,63 0,89 17,89 1,31 
C18 hsa-miR-125b-4373148 21,35 4,61 19,13 2,56 
C19 hsa-miR-126-4395339 30,15 13,41 18,92 2,35 
C20 hsa-miR-127-3p-4373147 17,15 0,41 29,42 12,85 
C21 hsa-miR-127-5p-4395340 31,64 14,90 Undetermined 
 C22 hsa-miR-128-4395327 23,45 6,71 22,90 6,33 
C23 hsa-miR-129-3p-4373297 28,98 12,24 26,90 10,33 
C24 hsa-miR-129-5p-4373171 34,02 17,28 28,60 12,03 
D1 hsa-miR-130a-4373145 21,17 4,43 20,23 3,66 
D2 hsa-miR-130b-4373144 20,03 3,29 20,17 3,60 
D3 hsa-miR-132-4373143 18,96 2,22 18,37 1,80 
D4 hsa-miR-133a-4395357 21,60 4,86 25,29 8,72 
D5 hsa-miR-133b-4395358 28,37 11,63 31,79 15,21 
D6 hsa-miR-134-4373299 21,77 5,03 28,99 12,42 
D7 hsa-miR-135a-4373140 24,99 8,24 23,89 7,32 
D8 hsa-miR-135b-4395372 21,27 4,53 29,13 12,56 
D9 hsa-miR-136-4373173 33,55 16,81 Undetermined 
 D10 hsa-miR-137-4373301 24,30 7,56 19,88 3,31 
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D11 hsa-miR-138-4395395 21,26 4,52 17,36 0,79 
D12 hsa-miR-139-3p-4395424 22,91 6,17 24,59 8,02 
D13 hsa-miR-139-5p-4395400 17,57 0,83 19,33 2,76 
D14 hsa-miR-140-3p-4395345 25,52 8,78 24,88 8,31 
D15 hsa-miR-140-5p-4373374 21,33 4,59 20,15 3,58 
D16 hsa-miR-141-4373137 33,57 16,83 34,98 18,40 
D17 hsa-miR-142-3p-4373136 31,73 14,99 30,37 13,80 
D18 hsa-miR-142-5p-4395359 Undetermined 
 
Undetermined 
 D19 hsa-miR-143-4395360 24,78 8,04 21,33 4,76 
D20 hsa-miR-145-4395389 20,66 3,92 18,74 2,16 
D21 hsa-miR-146a-4373132 27,41 10,67 26,38 9,81 
D22 hsa-miR-146b-3p-4395472 33,62 16,88 31,05 14,48 
D23 hsa-miR-146b-5p-4373178 22,11 5,37 21,78 5,21 
D24 hsa-miR-147b-4395373 Undetermined 
 
Undetermined 
 E1 hsa-miR-148a-4373130 24,28 7,54 23,84 7,26 
E2 hsa-miR-148b-4373129 25,82 9,08 25,82 9,25 
E3 hsa-miR-149-4395366 16,81 0,07 17,29 0,72 
E4 hsa-miR-150-4373127 28,03 11,29 27,40 10,83 
E5 hsa-miR-152-4395170 22,83 6,09 19,36 2,79 
E6 hsa-miR-153-4373305 37,36 20,62 32,62 16,05 
E7 hsa-miR-154-4373270 31,13 14,39 Undetermined 
 E8 hsa-miR-181a-4373117 23,90 7,16 22,31 5,73 
E9 hsa-miR-181c-4373115 32,85 16,11 29,19 12,62 
E10 hsa-miR-182-4395445 26,54 9,80 32,81 16,24 
E11 RNU48-4373383 15,10 
 
14,90 
 E12 hsa-miR-183-4395380 26,35 9,61 32,94 16,37 
E13 hsa-miR-184-4373113 28,97 12,23 23,78 7,21 
E14 hsa-miR-185-4395382 24,91 8,17 23,96 7,39 
E15 hsa-miR-186-4395396 17,80 1,06 19,31 2,74 
E16 hsa-miR-187-4373307 36,43 19,69 29,50 12,93 
E17 hsa-miR-188-3p-4395217 Undetermined 
 
Undetermined 
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E18 hsa-miR-190-4373110 30,20 13,46 29,37 12,80 
E19 hsa-miR-191-4395410 15,85 -0,89 15,46 -1,12 
E20 hsa-miR-192-4373108 23,67 6,93 24,05 7,48 
E21 hsa-miR-193a-3p-4395361 35,22 18,48 38,98 22,40 
E22 hsa-miR-193a-5p-4395392 26,18 9,44 24,99 8,41 
E23 hsa-miR-193b-4395478 17,91 1,17 19,74 3,16 
E24 hsa-miR-194-4373106 24,40 7,66 24,18 7,61 
F1 hsa-miR-195-4373105 24,24 7,50 20,17 3,59 
F2 hsa-miR-196b-4395326 Undetermined 
 
Undetermined 
 F3 hsa-miR-197-4373102 20,60 3,86 21,23 4,66 
F4 hsa-miR-198-4395384 Undetermined 
 
36,48 19,91 
F5 hsa-miR-199a-5p-4373272 34,31 17,57 25,65 9,08 
F6 hsa-miR-199a-3p-4395415 25,28 8,54 17,70 1,13 
F7 hsa-miR-199b-5p-4373100 39,46 22,72 26,76 10,19 
F8 hsa-miR-200a-4378069 Undetermined 
 
Undetermined 
 F9 hsa-miR-200b-4395362 38,42 21,68 35,59 19,02 
F10 hsa-miR-200c-4395411 26,52 9,77 28,53 11,96 
F11 hsa-miR-202-4395474 Undetermined 
 
Undetermined 
 F12 hsa-miR-203-4373095 25,09 8,35 25,68 9,11 
F13 hsa-miR-204-4373094 22,27 5,53 32,08 15,51 
F14 hsa-miR-205-4373093 31,46 14,71 32,39 15,82 
F15 hsa-miR-208b-4395401 Undetermined 
 
Undetermined 
 F16 hsa-miR-210-4373089 21,28 4,54 20,85 4,28 
F17 hsa-miR-214-4395417 27,15 10,41 17,28 0,70 
F18 hsa-miR-215-4373084 26,24 9,50 34,75 18,18 
F19 hsa-miR-216a-4395331 Undetermined 
 
Undetermined 
 F20 hsa-miR-216b-4395437 Undetermined 
 
Undetermined 
 F21 hsa-miR-217-4395448 Undetermined 
 
Undetermined 
 F22 hsa-miR-218-4373081 16,38 -0,36 15,59 -0,98 
F23 hsa-miR-219-5p-4373080 Undetermined 
 
Undetermined 
 F24 hsa-miR-221-4373077 Undetermined 
 
24,97 8,40 
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G1 hsa-miR-222-4395387 29,48 12,74 21,79 5,21 
G2 hsa-miR-223-4395406 30,71 13,97 29,55 12,98 
G3 hsa-miR-224-4395210 26,89 10,15 31,62 15,05 
G4 hsa-miR-296-3p-4395212 Undetermined 
 
28,29 11,72 
G5 hsa-miR-296-5p-4373066 32,57 15,83 22,81 6,24 
G6 hsa-miR-299-3p-4373189 Undetermined 
 
Undetermined 
 G7 hsa-miR-299-5p-4373188 25,95 9,21 Undetermined 
 G8 hsa-miR-301a-4373064 21,16 4,42 19,31 2,74 
G9 hsa-miR-301b-4395503 22,30 5,56 21,68 5,11 
G10 hsa-miR-302a-4378070 33,46 16,72 33,08 16,50 
G11 ath-miR159a-4373390 Undetermined 
 
Undetermined 
 G12 hsa-miR-302b-4378071 33,42 16,68 28,22 11,65 
G13 hsa-miR-302c-4378072 33,96 17,22 33,06 16,49 
G14 hsa-miR-320-4395388 17,85 1,11 17,26 0,69 
G15 hsa-miR-323-3p-4395338 18,34 1,60 24,94 8,37 
G16 hsa-miR-324-3p-4395272 20,64 3,90 21,16 4,59 
G17 hsa-miR-324-5p-4373052 21,15 4,41 19,94 3,36 
G18 hsa-miR-326-4373050 33,52 16,78 34,62 18,05 
G19 hsa-miR-328-4373049 22,88 6,14 21,13 4,55 
G20 hsa-miR-329-4373191 27,02 10,28 36,69 20,11 
G21 hsa-miR-330-3p-4373047 27,11 10,37 25,87 9,30 
G22 hsa-miR-330-5p-4395341 37,74 21,00 33,78 17,21 
G23 hsa-miR-331-3p-4373046 18,21 1,47 18,26 1,69 
G24 hsa-miR-331-5p-4395344 24,49 7,75 25,49 8,91 
H1 hsa-miR-335-4373045 25,04 8,30 25,48 8,91 
H2 hsa-miR-337-5p-4395267 25,19 8,45 Undetermined 
 H3 hsa-miR-338-3p-4395363 31,73 14,99 27,58 11,01 
H4 hsa-miR-339-3p-4395295 22,25 5,51 21,99 5,42 
H5 hsa-miR-339-5p-4395368 22,38 5,64 22,89 6,32 
H6 hsa-miR-340-4395369 22,95 6,21 23,12 6,55 
H7 has-miR-155-4395459 23,49 6,75 26,50 9,93 
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H8 hsa-let-7b-4395446 28,54 11,80 19,59 3,02 
H9 hsa-miR-342-3p-4395371 16,45 -0,29 17,07 0,50 
H10 hsa-miR-342-5p-4395258 35,00 18,26 32,34 15,77 
H11 hsa-miR-345-4395297 17,57 0,83 18,22 1,65 
H12 hsa-miR-361-5p-4373035 24,12 7,38 22,37 5,80 
H13 hsa-miR-362-3p-4395228 28,54 11,80 28,32 11,75 
H14 hsa-miR-362-5p-4378092 24,97 8,23 24,02 7,44 
H15 hsa-miR-363-4378090 28,13 11,39 25,44 8,87 
H16 hsa-miR-365-4373194 23,99 7,25 26,36 9,78 
H17 hsa-miR-367-4373034 32,26 15,52 30,29 13,72 
H18 hsa-miR-369-3p-4373032 30,19 13,45 36,67 20,10 
H19 hsa-miR-369-5p-4373195 29,14 12,40 35,63 19,05 
H20 hsa-miR-370-4395386 19,78 3,04 25,45 8,88 
H21 hsa-miR-371-3p-4395235 Undetermined 
 
Undetermined 
 H22 hsa-miR-372-4373029 29,50 12,76 32,92 16,34 
H23 hsa-miR-373-4378073 Undetermined 
 
Undetermined 
 H24 hsa-miR-374a-4373028 21,87 5,13 20,47 3,90 
I1 hsa-miR-374b-4381045 20,38 3,64 19,47 2,90 
I2 hsa-miR-375-4373027 17,85 1,11 18,26 1,69 
I3 hsa-miR-376a-4373026 18,41 1,67 25,50 8,93 
I4 hsa-miR-376b-4373196 31,16 14,42 Undetermined 
 I5 hsa-miR-377-4373025 Undetermined 
 
Undetermined 
 I6 hsa-miR-379-4373349 21,37 4,63 26,84 10,27 
I7 hsa-miR-380-4373022 31,04 14,30 Undetermined 
 I8 hsa-miR-381-4373020 29,73 12,99 36,04 19,46 
I9 hsa-miR-382-4373019 20,41 3,67 25,12 8,55 
I10 hsa-miR-383-4373018 26,08 9,34 29,79 13,22 
I11 hsa-miR-409-5p-4395442 26,68 9,94 34,38 17,81 
I12 hsa-miR-410-4378093 21,22 4,48 27,82 11,25 
I13 hsa-miR-411-4381013 20,75 4,01 25,94 9,37 
I14 hsa-miR-422a-4395408 29,76 13,02 32,42 15,84 
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I15 hsa-miR-423-5p-4395451 27,00 10,26 25,04 8,47 
I16 hsa-miR-424-4373201 30,67 13,93 27,98 11,41 
I17 hsa-miR-425-4380926 24,48 7,74 22,87 6,30 
I18 hsa-miR-429-4373203 Undetermined 
 
39,15 22,58 
I19 hsa-miR-431-4395173 19,54 2,80 Undetermined 
 I20 hsa-miR-433-4373205 20,53 3,79 36,05 19,48 
I21 hsa-miR-449a-4373207 36,64 19,90 29,94 13,37 
I22 hsa-miR-449b-4381011 Undetermined 
 
31,14 14,57 
I23 hsa-miR-450a-4395414 33,02 16,28 31,28 14,71 
I24 hsa-miR-450b-3p-4395319 Undetermined 
 
Undetermined 
 J1 hsa-miR-450b-5p-4395318 31,70 14,96 31,15 14,57 
J2 hsa-miR-451-4373360 Undetermined 
 
Undetermined 
 J3 hsa-miR-452-4395440 29,93 13,19 Undetermined 
 J4 hsa-miR-453-4395429 27,12 10,38 Undetermined 
 J5 hsa-miR-454-4395434 17,54 0,80 18,16 1,59 
J6 hsa-miR-455-3p-4395355 27,70 10,96 24,77 8,19 
J7 hsa-miR-455-5p-4378098 31,00 14,26 27,68 11,11 
J8 hsa-miR-483-5p-4395449 27,27 10,53 22,95 6,38 
J9 hsa-miR-484-4381032 15,37 -1,37 16,25 -0,33 
J10 hsa-miR-485-3p-4378095 21,59 4,85 28,87 12,29 
J11 hsa-miR-485-5p-4373212 29,10 12,36 Undetermined 
 J12 hsa-miR-486-3p-4395204 38,59 21,85 Undetermined 
 J13 hsa-miR-486-5p-4378096 26,05 9,31 27,94 11,37 
J14 hsa-miR-487a-4378097 27,34 10,60 36,68 20,11 
J15 hsa-miR-487b-4378102 22,32 5,58 28,90 12,32 
J16 hsa-miR-488-4395468 27,56 10,82 29,06 12,49 
J17 hsa-miR-489-4395469 26,57 9,83 24,48 7,91 
J18 hsa-miR-490-3p-4373215 27,82 11,08 27,34 10,77 
J19 hsa-miR-491-3p-4395471 Undetermined 
 
Undetermined 
 J20 hsa-miR-491-5p-4381053 22,92 6,18 23,10 6,53 
J21 hsa-miR-493-4395475 25,06 8,32 38,71 22,14 
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J22 hsa-miR-494-4395476 21,37 4,63 28,23 11,66 
J23 hsa-miR-495-4381078 21,30 4,56 27,03 10,46 
J24 hsa-miR-496-4386771 30,20 13,46 Undetermined 
 K1 hsa-miR-499-3p-4395538 Undetermined 
 
Undetermined 
 K2 hsa-miR-499-5p-4381047 36,70 19,96 37,37 20,80 
K3 hsa-miR-500-4395539 24,93 8,19 24,27 7,69 
K4 hsa-miR-501-3p-4395546 27,77 11,03 29,12 12,55 
K5 hsa-miR-501-5p-4373226 24,58 7,84 24,23 7,66 
K6 hsa-miR-502-3p-4395194 29,21 12,47 27,61 11,04 
K7 hsa-miR-502-5p-4373227 29,44 12,69 28,07 11,50 
K8 hsa-miR-503-4373228 30,43 13,69 27,91 11,33 
K9 hsa-miR-504-4395195 24,70 7,96 Undetermined 
 K10 hsa-miR-505-4395200 25,14 8,40 25,53 8,96 
K11 hsa-miR-507-4373232 Undetermined 
 
Undetermined 
 K12 hsa-miR-508-3p-4373233 32,34 15,60 39,03 22,46 
K13 hsa-miR-508-5p-4395203 Undetermined 
 
Undetermined 
 K14 hsa-miR-509-5p-4395346 Undetermined 
 
33,78 17,21 
K15 hsa-miR-510-4395352 Undetermined 
 
Undetermined 
 K16 hsa-miR-512-3p-4381034 32,11 15,37 Undetermined 
 K17 hsa-miR-512-5p-4373238 Undetermined 
 
Undetermined 
 K18 hsa-miR-513-5p-4395201 Undetermined 
 
Undetermined 
 K19 hsa-miR-515-3p-4395480 Undetermined 
 
Undetermined 
 K20 hsa-miR-515-5p-4373242 Undetermined 
 
Undetermined 
 K21 hsa-miR-516a-5p-4395527 Undetermined 
 
Undetermined 
 K22 hsa-miR-516b-4395172 Undetermined 
 
Undetermined 
 K23 hsa-miR-517a-4395513 37,95 21,21 Undetermined 
 K24 hsa-miR-517c-4373264 Undetermined 
 
Undetermined 
 L1 hsa-miR-518a-3p-4395508 Undetermined 
 
Undetermined 
 L2 hsa-miR-518a-5p-4395507 Undetermined 
 
Undetermined 
 L3 hsa-miR-518b-4373246 35,31 18,57 31,95 15,37 
L4 hsa-miR-518c-4395512 Undetermined 
 
Undetermined 
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L5 hsa-miR-518d-3p-4373248 Undetermined 
 
Undetermined 
 L6 hsa-miR-518d-5p-4395500 Undetermined 
 
Undetermined 
 L7 hsa-miR-518e-4395506 Undetermined 
 
Undetermined 
 L8 hsa-miR-518f-4395499 25,26 8,52 24,59 8,02 
L9 hsa-miR-519a-4395526 Undetermined 
 
Undetermined 
 L10 hsa-miR-519d-4395514 Undetermined 
 
Undetermined 
 L11 hsa-miR-519e-4395481 Undetermined 
 
Undetermined 
 L12 hsa-miR-520a-3p-4373268 Undetermined 
 
Undetermined 
 L13 hsa-miR-520a-5p-4378085 Undetermined 
 
Undetermined 
 L14 hsa-miR-520d-5p-4395504 Undetermined 
 
Undetermined 
 L15 hsa-miR-520g-4373257 Undetermined 
 
Undetermined 
 L16 hsa-miR-521-4373259 Undetermined 
 
Undetermined 
 L17 hsa-miR-522-4395524 Undetermined 
 
Undetermined 
 L18 hsa-miR-523-4395497 27,24 10,50 28,94 12,37 
L19 hsa-miR-524-5p-4395174 Undetermined 
 
Undetermined 
 L20 hsa-miR-525-3p-4395496 Undetermined 
 
Undetermined 
 L21 hsa-miR-525-5p-4378088 Undetermined 
 
Undetermined 
 L22 hsa-miR-526b-4395493 Undetermined 
 
Undetermined 
 L23 hsa-miR-532-3p-4395466 20,61 3,87 20,47 3,89 
L24 hsa-miR-532-5p-4380928 20,26 3,52 19,72 3,15 
M1 hsa-miR-539-4378103 18,57 1,83 24,32 7,75 
M2 hsa-miR-541-4395312 26,02 9,28 39,21 22,64 
M3 hsa-miR-542-3p-4378101 32,04 15,30 29,85 13,27 
M4 hsa-miR-542-5p-4395351 30,29 13,55 31,17 14,60 
M5 hsa-miR-544-4395376 Undetermined 
 
Undetermined 
 M6 hsa-miR-545-4395378 31,77 15,03 29,16 12,59 
M7 hsa-miR-548a-3p-4380948 Undetermined 
 
Undetermined 
 M8 hsa-miR-548a-5p-4395523 Undetermined 
 
Undetermined 
 M9 hsa-miR-548b-3p-4380951 Undetermined 
 
Undetermined 
 M10 hsa-miR-548b-5p-4395519 30,30 13,56 31,12 14,55 
M11 hsa-miR-548c-3p-4380993 Undetermined 
 
Undetermined 
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M12 hsa-miR-548c-5p-4395540 34,08 17,34 33,34 16,76 
M13 hsa-miR-548d-3p-4381008 33,88 17,14 38,34 21,77 
M14 hsa-miR-548d-5p-4395348 31,93 15,19 32,12 15,55 
M15 hsa-miR-551b-4380945 31,24 14,50 28,27 11,69 
M16 hsa-miR-556-3p-4395456 Undetermined 
 
Undetermined 
 M17 hsa-miR-556-5p-4395455 Undetermined 
 
Undetermined 
 M18 hsa-miR-561-4380938 37,01 20,27 Undetermined 
 M19 hsa-miR-570-4395458 35,01 18,27 33,25 16,68 
M20 hsa-miR-574-3p-4395460 23,15 6,41 19,95 3,38 
M21 hsa-miR-576-3p-4395462 27,07 10,33 26,44 9,87 
M22 hsa-miR-576-5p-4395461 36,77 20,03 33,85 17,27 
M23 hsa-miR-579-4395509 28,70 11,96 29,83 13,26 
M24 hsa-miR-582-3p-4395510 Undetermined 
 
33,62 17,05 
N1 hsa-miR-582-5p-4395175 Undetermined 
 
33,97 17,40 
N2 hsa-miR-589-4395520 31,56 14,82 31,47 14,90 
N3 hsa-miR-590-5p-4395176 22,34 5,60 21,07 4,50 
N4 hsa-miR-597-4380960 26,54 9,80 27,65 11,08 
N5 hsa-miR-598-4395179 22,40 5,66 21,31 4,73 
N6 hsa-miR-615-3p-4386777 27,01 10,27 26,46 9,89 
N7 hsa-miR-615-5p-4395464 38,47 21,73 36,16 19,59 
N8 hsa-miR-616-4395525 32,49 15,75 31,98 15,41 
N9 hsa-miR-618-4380996 25,19 8,45 25,96 9,39 
N10 hsa-miR-624-4395541 Undetermined 
 
Undetermined 
 N11 hsa-miR-625-4395542 27,93 11,19 27,36 10,78 
N12 hsa-miR-627-4380967 35,48 18,74 33,88 17,31 
N13 hsa-miR-628-5p-4395544 23,20 6,46 23,44 6,87 
N14 hsa-miR-629-4395547 26,50 9,76 28,23 11,65 
N15 hsa-miR-636-4395199 25,55 8,81 26,32 9,74 
N16 hsa-miR-642-4380995 25,32 8,58 26,53 9,96 
N17 hsa-miR-651-4381007 36,58 19,84 36,11 19,54 
N18 hsa-miR-652-4395463 21,31 4,57 21,67 5,10 
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N19 hsa-miR-653-4395403 Undetermined 
 
Undetermined 
 N20 hsa-miR-654-3p-4395350 27,95 11,21 Undetermined 
 N21 hsa-miR-654-5p-4381014 23,20 6,46 29,90 13,33 
N22 hsa-miR-655-4381015 27,27 10,53 36,56 19,99 
N23 hsa-miR-660-4380925 23,20 6,46 22,00 5,43 
N24 hsa-miR-671-3p-4395433 23,71 6,97 23,58 7,01 
O1 hsa-miR-672-4395438 33,54 16,80 Undetermined 
 O2 hsa-miR-674-4395193 Undetermined 
 
Undetermined 
 O3 hsa-miR-708-4395452 18,13 1,39 17,44 0,86 
O4 hsa-miR-744-4395435 20,51 3,77 19,50 2,93 
O5 hsa-miR-758-4395180 22,10 5,36 29,62 13,05 
O6 hsa-miR-871-4395465 Undetermined 
 
Undetermined 
 O7 hsa-miR-872-4395375 Undetermined 
 
Undetermined 
 O8 hsa-miR-873-4395467 28,95 12,21 32,00 15,43 
O9 hsa-miR-874-4395379 29,33 12,59 31,77 15,20 
O10 hsa-miR-875-3p-4395315 Undetermined 
 
Undetermined 
 O11 hsa-miR-876-3p-4395336 28,47 11,73 28,25 11,68 
O12 hsa-miR-876-5p-4395316 29,80 13,06 30,66 14,08 
O13 hsa-miR-885-3p-4395483 Undetermined 
 
Undetermined 
 O14 hsa-miR-885-5p-4395407 22,69 5,95 22,49 5,92 
O15 hsa-miR-886-3p-4395305 Undetermined 
 
Undetermined 
 O16 hsa-miR-886-5p-4395304 33,17 16,43 37,94 21,37 
O17 hsa-miR-887-4395485 34,44 17,70 31,72 15,15 
O18 hsa-miR-888-4395323 33,85 17,11 Undetermined 
 O19 hsa-miR-889-4395313 24,93 8,19 35,09 18,51 
O20 hsa-miR-890-4395320 Undetermined 
 
Undetermined 
 O21 hsa-miR-891a-4395302 35,79 19,05 Undetermined 
 O22 hsa-miR-891b-4395321 Undetermined 
 
Undetermined 
 O23 hsa-miR-892a-4395306 Undetermined 
 
Undetermined 
 O24 hsa-miR-147-4373131 35,84 19,10 35,11 18,54 
P1 hsa-miR-208-4373091 29,85 13,11 25,25 8,68 
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P2 hsa-miR-211-4373088 Undetermined 
 
Undetermined 
 P3 hsa-miR-212-4373087 23,60 6,86 24,53 7,95 
P4 hsa-miR-219-1-3p-4395206 30,96 14,22 29,81 13,24 
P5 hsa-miR-219-2-3p-4395501 Undetermined 
 
Undetermined 
 P6 hsa-miR-220-4373078 Undetermined 
 
Undetermined 
 P7 hsa-miR-220b-4395317 Undetermined 
 
Undetermined 
 P8 hsa-miR-220c-4395322 Undetermined 
 
Undetermined 
 P9 hsa-miR-298-4395301 Undetermined 
 
Undetermined 
 P10 hsa-miR-325-4373051 Undetermined 
 
Undetermined 
 P11 hsa-miR-346-4373038 31,12 14,38 31,41 14,83 
P12 hsa-miR-376c-4395233 20,14 3,40 26,75 10,17 
P13 hsa-miR-384-4373017 Undetermined 
 
Undetermined 
 P14 hsa-miR-412-4373199 34,49 17,75 Undetermined 
 P15 hsa-miR-448-4373206 36,74 20,00 Undetermined 
 P16 hsa-miR-492-4373217 Undetermined 
 
Undetermined 
 P17 hsa-miR-506-4373231 33,77 17,03 Undetermined 
 P18 hsa-miR-509-3-5p-4395266 Undetermined 
 
Undetermined 
 P19 hsa-miR-511-4373236 Undetermined 
 
Undetermined 
 P20 hsa-miR-517b-4373244 Undetermined 
 
Undetermined 
 P21 hsa-miR-519c-3p-4373251 Undetermined 
 
Undetermined 
 P22 hsa-miR-520b-4373252 Undetermined 
 
37,83 21,26 
P23 hsa-miR-520e-4373255 Undetermined 
 
Undetermined 
 P24 hsa-miR-520f-4373256 39,17 22,43 37,50 20,93 
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APPENDIX 2 
 
TaqMan Human microRNA Array B v. 3.0 (Applied 
Biosystems). 
 
  
LAN-5 
 
SH-SY5Y 
 Pos Detector Ct ∆Ct Ct ∆Ct 
A1 dme-miR-7-000268 24,12 7,51 22,60 22,60 
A2 hsa-miR-548I-002909 Undetermined 
 
Undetermined 
 A3 hsa-miR-30a-3p-000416 20,81 4,21 20,32 20,32 
A4 hsa-miR-30a-5p-000417 21,08 4,48 19,97 19,97 
A5 hsa-miR-30d-000420 24,91 8,31 23,66 23,66 
A6 hsa-miR-30e-3p-000422 20,88 4,28 19,89 19,89 
A7 hsa-miR-34b-000427 Undetermined 
 
35,04 35,04 
A8 hsa-miR-126#-000451 Undetermined 
 
25,32 25,32 
A9 hsa-miR-154#-000478 25,78 9,17 32,04 32,04 
A10 hsa-miR-182#-000483 Undetermined 
 
Undetermined 
 A11 U6 snRNA-001973 17,28 
   A12 U6 snRNA-001973 17,50 
 
17,42 
 A13 hsa-miR-206-000510 32,07 15,46 29,35 29,35 
A14 hsa-miR-213-000516 25,32 8,72 29,70 29,70 
A15 hsa-miR-302c#-000534 31,90 15,29 36,27 36,27 
A16 hsa-miR-302d-000535 32,05 15,45 32,90 32,90 
A17 hsa-miR-378-000567 27,75 11,14 31,96 31,96 
A18 hsa-miR-380-5p-000570 27,47 10,87 35,76 35,76 
A19 hsa-miR-1257-002910 34,82 18,22 Undetermined 
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A20 hsa-miR-200a#-001011 Undetermined 
 
Undetermined 
 A21 hsa-miR-432-001026 19,85 3,24 31,89 31,89 
A22 hsa-miR-432#-001027 31,98 15,38 Undetermined 
 A23 hsa-miR-497-001043 Undetermined 
 
25,19 25,19 
A24 hsa-miR-500-001046 29,20 12,60 29,23 29,23 
B1 hsa-miR-1238-002927 Undetermined 
 
Undetermined 
 B2 hsa-miR-488-001106 29,84 13,24 30,63 30,63 
B3 hsa-miR-517#-001113 Undetermined 
 
Undetermined 
 B4 hsa-miR-516-3p-001149 34,73 18,13 36,54 36,54 
B5 hsa-miR-518c#-001158 Undetermined 
 
Undetermined 
 B6 hsa-miR-519e#-001166 Undetermined 
 
Undetermined 
 B7 hsa-miR-520h-001170 Undetermined 
 
Undetermined 
 B8 hsa-miR-524-001173 Undetermined 
 
Undetermined 
 B9 mmu-let-7d#-001178 Undetermined 
 
Undetermined 
 B10 hsa-miR-363#-001283 36,83 20,22 30,10 30,10 
B11 U6 snRNA-001973 16,91 
 
16,91 
 B12 U6 snRNA-001973 16,77 
 
18,63 
 B13 rno-miR-7#-001338 20,29 3,69 20,86 20,86 
B14 hsa-miR-656-001510 26,03 9,43 Undetermined 
 B15 hsa-miR-549-001511 Undetermined 
 
Undetermined 
 B16 hsa-miR-657-001512 36,76 20,16 37,54 37,54 
B17 hsa-miR-658-001513 Undetermined 
 
Undetermined 
 B18 hsa-miR-659-001514 Undetermined 
 
38,98 38,98 
B19 hsa-miR-551a-001519 Undetermined 
 
36,51 36,51 
B20 hsa-miR-552-001520 Undetermined 
 
Undetermined 
 B21 hsa-miR-553-001521 Undetermined 
 
Undetermined 
 B22 hsa-miR-554-001522 Undetermined 
 
Undetermined 
 B23 hsa-miR-555-001523 Undetermined 
 
Undetermined 
 B24 hsa-miR-557-001525 Undetermined 
 
Undetermined 
 C1 hsa-miR-558-001526 Undetermined 
 
Undetermined 
 C2 hsa-miR-559-001527 Undetermined 
 
Undetermined 
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C3 hsa-miR-562-001529 Undetermined 
 
Undetermined 
 C4 hsa-miR-563-001530 Undetermined 
 
Undetermined 
 C5 hsa-miR-564-001531 28,91 12,31 31,61 31,61 
C6 hsa-miR-566-001533 38,53 21,93 Undetermined 
 C7 hsa-miR-567-001534 Undetermined 
 
Undetermined 
 C8 hsa-miR-569-001536 Undetermined 
 
Undetermined 
 C9 hsa-miR-586-001539 33,46 16,86 Undetermined 
 C10 hsa-miR-587-001540 Undetermined 
 
Undetermined 
 C11 RNU44-001094 16,10 
 
16,20 
 C12 hsa-miR-588-001542 Undetermined 
 
Undetermined 
 C13 hsa-miR-589-001543 24,34 7,74 23,79 23,79 
C14 hsa-miR-550-001544 30,13 13,53 34,11 34,11 
C15 hsa-miR-591-001545 Undetermined 
 
Undetermined 
 C16 hsa-miR-592-001546 20,07 3,47 23,89 23,89 
C17 hsa-miR-593-001547 Undetermined 
 
Undetermined 
 C18 hsa-miR-596-001550 34,36 17,76 33,56 33,56 
C19 hsa-miR-622-001553 Undetermined 
 
Undetermined 
 C20 hsa-miR-599-001554 Undetermined 
 
Undetermined 
 C21 hsa-miR-623-001555 Undetermined 
 
Undetermined 
 C22 hsa-miR-600-001556 Undetermined 
 
Undetermined 
 C23 hsa-miR-624-001557 32,94 16,33 33,56 33,56 
C24 hsa-miR-601-001558 31,45 14,85 29,87 29,87 
D1 hsa-miR-626-001559 Undetermined 
 
Undetermined 
 D2 hsa-miR-629-001562 24,27 7,66 25,80 25,80 
D3 hsa-miR-630-001563 35,63 19,02 Undetermined 
 D4 hsa-miR-631-001564 Undetermined 
 
Undetermined 
 D5 hsa-miR-603-001566 Undetermined 
 
Undetermined 
 D6 hsa-miR-604-001567 36,86 20,26 38,26 38,26 
D7 hsa-miR-605-001568 Undetermined 
 
Undetermined 
 D8 hsa-miR-606-001569 Undetermined 
 
Undetermined 
 D9 hsa-miR-607-001570 Undetermined 
 
Undetermined 
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D10 hsa-miR-608-001571 Undetermined 
 
Undetermined 
 D11 hsa-miR-609-001573 Undetermined 
 
Undetermined 
 D12 hsa-miR-633-001574 Undetermined 
 
Undetermined 
 D13 hsa-miR-634-001576 Undetermined 
 
Undetermined 
 D14 hsa-miR-635-001578 Undetermined 
 
Undetermined 
 D15 hsa-miR-637-001581 Undetermined 
 
Undetermined 
 D16 hsa-miR-638-001582 32,21 15,61 31,18 31,18 
D17 hsa-miR-639-001583 28,92 12,32 32,69 32,69 
D18 hsa-miR-640-001584 Undetermined 
 
Undetermined 
 D19 hsa-miR-641-001585 32,12 15,52 31,82 31,82 
D20 hsa-miR-613-001586 Undetermined 
 
Undetermined 
 D21 hsa-miR-614-001587 39,80 23,20 Undetermined 
 D22 hsa-miR-616-001589 31,32 14,71 31,45 31,45 
D23 hsa-miR-617-001591 36,79 20,18 Undetermined 
 D24 hsa-miR-643-001594 36,36 19,75 31,66 31,66 
E1 hsa-miR-644-001596 Undetermined 
 
Undetermined 
 E2 hsa-miR-645-001597 36,20 19,60 32,84 32,84 
E3 hsa-miR-621-001598 Undetermined 
 
Undetermined 
 E4 hsa-miR-646-001599 28,00 11,40 27,25 27,25 
E5 hsa-miR-647-001600 Undetermined 
 
Undetermined 
 E6 hsa-miR-648-001601 Undetermined 
 
Undetermined 
 E7 hsa-miR-649-001602 Undetermined 
 
Undetermined 
 E8 hsa-miR-650-001603 Undetermined 
 
Undetermined 
 E9 hsa-miR-661-001606 34,27 17,67 33,45 33,45 
E10 hsa-miR-662-001607 Undetermined 
 
Undetermined 
 E11 RNU48-001006 15,06 
 
15,11 
 E12 hsa-miR-571-001613 37,46 20,86 37,87 37,87 
E13 hsa-miR-572-001614 27,81 11,21 29,59 29,59 
E14 hsa-miR-573-001615 38,90 22,29 39,74 39,74 
E15 hsa-miR-575-001617 Undetermined 
 
Undetermined 
 E16 hsa-miR-578-001619 Undetermined 
 
39,36 39,36 
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E17 hsa-miR-580-001621 31,63 15,02 31,52 31,52 
E18 hsa-miR-581-001622 Undetermined 
 
Undetermined 
 E19 hsa-miR-583-001623 Undetermined 
 
Undetermined 
 E20 hsa-miR-584-001624 Undetermined 
 
Undetermined 
 E21 hsa-miR-585-001625 Undetermined   Undetermined 
 E22 rno-miR-29c#-001818 30,50 13,90 29,64 29,64 
E23 hsa-miR-766-001986 20,34 3,73 19,20 19,20 
E24 hsa-miR-595-001987 Undetermined 
 
Undetermined 
 F1 hsa-miR-668-001992 22,95 6,35 38,57 38,57 
F2 hsa-miR-767-5p-001993 26,33 9,72 27,32 27,32 
F3 hsa-miR-767-3p-001995 34,47 17,86 Undetermined 
 F4 hsa-miR-454#-001996 25,16 8,56 27,01 27,01 
F5 hsa-miR-769-5p-001998 23,16 6,56 21,79 21,79 
F6 hsa-miR-770-5p-002002 22,89 6,28 36,19 36,19 
F7 hsa-miR-769-3p-002003 31,88 15,28 29,70 29,70 
F8 hsa-miR-802-002004 Undetermined 
 
Undetermined 
 F9 hsa-miR-675-002005 39,72 23,12 26,42 26,42 
F10 hsa-miR-505#-002087 24,56 7,96 23,33 23,33 
F11 hsa-miR-218-1#-002094 Undetermined 
 
Undetermined 
 F12 hsa-miR-221#-002096 Undetermined 
 
Undetermined 
 F13 hsa-miR-222#-002097 Undetermined 
 
Undetermined 
 F14 hsa-miR-223#-002098 Undetermined 
 
Undetermined 
 F15 hsa-miR-136#-002100 24,35 7,75 Undetermined 
 F16 hsa-miR-34b-002102 33,82 17,22 27,83 27,83 
F17 hsa-miR-185#-002104 Undetermined 
 
Undetermined 
 F18 hsa-miR-186#-002105 Undetermined 
 
Undetermined 
 F19 hsa-miR-195#-002107 Undetermined 
 
Undetermined 
 F20 hsa-miR-30c-1#-002108 Undetermined 
 
37,61 37,61 
F21 hsa-miR-30c-2#-002110 Undetermined 
 
Undetermined 
 F22 hsa-miR-32#-002111 Undetermined 
 
Undetermined 
 F23 hsa-miR-31#-002113 Undetermined 
 
Undetermined 
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F24 hsa-miR-130b#-002114 24,20 7,60 27,02 27,02 
G1 hsa-miR-26a-2#-002115 31,92 15,32 32,32 32,32 
G2 hsa-miR-361-3p-002116 35,35 18,75 30,94 30,94 
G3 hsa-let-7g#-002118 32,64 16,04 33,69 33,69 
G4 hsa-miR-302b#-002119 Undetermined 
 
Undetermined 
 G5 hsa-miR-302d#-002120 Undetermined 
 
Undetermined 
 G6 hsa-miR-367#-002121 Undetermined 
 
Undetermined 
 G7 hsa-miR-374a#-002125 31,59 14,99 30,57 30,57 
G8 hsa-miR-23b#-002126 36,75 20,15 35,75 35,75 
G9 hsa-miR-376a#-002127 29,57 12,97 Undetermined 
 G10 hsa-miR-377#-002128 27,05 10,45 35,33 35,33 
G11 ath-miR159a-000338 Undetermined 
 
Undetermined 
 G12 hsa-miR-30b#-002129 Undetermined 
 
Undetermined 
 G13 hsa-miR-122#-002130 Undetermined 
 
Undetermined 
 G14 hsa-miR-130a#-002131 Undetermined 
 
Undetermined 
 G15 hsa-miR-132#-002132 34,35 17,75 35,12 35,12 
G16 hsa-miR-148a#-002134 35,52 18,91 Undetermined 
 G17 hsa-miR-33a-002135 36,71 20,11 38,71 38,71 
G18 hsa-miR-33a#-002136 27,23 10,63 28,19 28,19 
G19 hsa-miR-92a-1#-002137 25,62 9,01 28,19 28,19 
G20 hsa-miR-92a-2#-002138 Undetermined 
 
Undetermined 
 G21 hsa-miR-93#-002139 18,51 1,90 18,43 18,43 
G22 hsa-miR-96#-002140 Undetermined 
 
Undetermined 
 G23 hsa-miR-99a#-002141 31,31 14,70 26,32 26,32 
G24 hsa-miR-100#-002142 Undetermined 
 
32,15 32,15 
H1 hsa-miR-101#-002143 Undetermined 
 
Undetermined 
 H2 hsa-miR-138-2#-002144 28,49 11,88 28,66 28,66 
H3 hsa-miR-141#-002145 Undetermined 
 
Undetermined 
 H4 hsa-miR-143#-002146 Undetermined 
 
Undetermined 
 H5 hsa-miR-144#-002148 Undetermined 
 
33,21 33,21 
H6 hsa-miR-145#-002149 30,48 13,88 27,92 27,92 
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H7 hsa-miR-920-002150 Undetermined 
 
Undetermined 
 H8 hsa-miR-921-002151 Undetermined 
 
Undetermined 
 H9 hsa-miR-922-002152 31,62 15,01 33,82 33,82 
H10 hsa-miR-924-002154 Undetermined 
 
Undetermined 
 H11 hsa-miR-337-3p-002157 30,00 13,40 Undetermined 
 H12 hsa-miR-125b-2#-002158 36,55 19,95 28,12 28,12 
H13 hsa-miR-135b#-002159 24,62 8,02 Undetermined 
 H14 hsa-miR-148b#-002160 27,48 10,88 26,40 26,40 
H15 hsa-miR-146a#-002163 Undetermined 
 
Undetermined 
 H16 hsa-miR-149#-002164 35,50 18,89 33,13 33,13 
H17 hsa-miR-29b-1#-002165 37,58 20,98 30,61 30,61 
H18 hsa-miR-29b-2#-002166 31,12 14,52 29,85 29,85 
H19 hsa-miR-105#-002168 33,76 17,15 Undetermined 
 H20 hsa-miR-106a#-002170 Undetermined 
 
Undetermined 
 H21 hsa-miR-16-2#-002171 Undetermined 
 
Undetermined 
 H22 hsa-let-7i#-002172 Undetermined 
 
30,03 30,03 
H23 hsa-miR-15b#-002173 23,92 7,32 23,32 23,32 
H24 hsa-miR-27b#-002174 24,66 8,06 25,34 25,34 
I1 hsa-miR-933-002176 Undetermined 
 
Undetermined 
 I2 hsa-miR-934-002177 Undetermined 
 
Undetermined 
 I3 hsa-miR-935-002178 Undetermined 
 
21,45 21,45 
I4 hsa-miR-936-002179 Undetermined 
 
Undetermined 
 I5 hsa-miR-937-002180 38,45 21,85 Undetermined 
 I6 hsa-miR-938-002181 Undetermined 
 
37,20 37,20 
I7 hsa-miR-939-002182 26,08 9,48 27,75 27,75 
I8 hsa-miR-941-002183 25,26 8,65 26,08 26,08 
I9 hsa-miR-335#-002185 26,77 10,17 30,50 30,50 
I10 hsa-miR-942-002187 24,35 7,75 25,21 25,21 
I11 hsa-miR-943-002188 29,20 12,60 32,96 32,96 
I12 hsa-miR-944-002189 37,34 20,74 Undetermined 
 I13 hsa-miR-99b#-002196 21,29 4,69 22,32 22,32 
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I14 hsa-miR-124#-002197 27,85 11,24 29,42 29,42 
I15 hsa-miR-541#-002200 31,14 14,54 Undetermined 
 I16 hsa-miR-875-5p-002203 28,45 11,84 30,13 30,13 
I17 hsa-miR-888#-002213 Undetermined 
 
Undetermined 
 I18 hsa-miR-892b-002214 36,99 20,38 38,52 38,52 
I19 hsa-miR-9#-002231 20,87 4,26 20,36 20,36 
I20 hsa-miR-411#-002238 25,19 8,59 35,01 35,01 
I21 hsa-miR-378-002243 21,58 4,98 24,06 24,06 
I22 hsa-miR-151-3p-002254 19,70 3,10 19,05 19,05 
I23 hsa-miR-340#-002259 23,49 6,89 23,13 23,13 
I24 hsa-miR-190b-002263 28,70 12,10 26,95 26,95 
J1 hsa-miR-545#-002266 32,24 15,63 31,87 31,87 
J2 hsa-miR-183#-002270 21,83 5,22 32,28 32,28 
J3 hsa-miR-192#-002272 31,06 14,46 31,34 31,34 
J4 hsa-miR-200b#-002274 Undetermined 
 
Undetermined 
 J5 hsa-miR-200c#-002286 Undetermined 
 
Undetermined 
 J6 hsa-miR-155#-002287 Undetermined 
 
Undetermined 
 J7 hsa-miR-10a#-002288 Undetermined 
 
Undetermined 
 J8 hsa-miR-214#-002293 37,00 20,40 23,12 23,12 
J9 hsa-miR-218-2#-002294 25,11 8,50 24,26 24,26 
J10 hsa-miR-129#-002298 30,16 13,56 26,14 26,14 
J11 hsa-miR-22#-002301 30,84 14,24 28,17 28,17 
J12 hsa-miR-425#-002302 22,44 5,83 22,17 22,17 
J13 hsa-miR-30d#-002305 26,62 10,02 26,09 26,09 
J14 hsa-let-7a#-002307 Undetermined 
 
35,91 35,91 
J15 hsa-miR-424#-002309 25,34 8,73 24,99 24,99 
J16 hsa-miR-18b#-002310 Undetermined 
 
Undetermined 
 J17 hsa-miR-20b#-002311 39,12 22,51 30,00 30,00 
J18 hsa-miR-431#-002312 27,71 11,10 Undetermined 
 J19 hsa-miR-7-2#-002314 24,12 7,52 30,83 30,83 
J20 hsa-miR-10b#-002315 22,81 6,20 20,43 20,43 
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J21 hsa-miR-34a#-002316 29,80 13,19 23,52 23,52 
J22 hsa-miR-181a-2#-002317 22,98 6,38 20,32 20,32 
J23 hsa-miR-744#-002325 28,33 11,73 27,65 27,65 
J24 hsa-miR-452#-002330 Undetermined 
 
Undetermined 
 K1 hsa-miR-409-3p-002332 15,35 -1,25 21,51 21,51 
K2 hsa-miR-181c#-002333 30,88 14,28 27,25 27,25 
K3 hsa-miR-196a#-002336 Undetermined 
 
Undetermined 
 K4 hsa-miR-483-3p-002339 Undetermined 
 
25,09 25,09 
K5 hsa-miR-708#-002342 39,32 22,72 37,20 37,20 
K6 hsa-miR-92b#-002343 32,16 15,56 32,28 32,28 
K7 hsa-miR-551b#-002346 28,96 12,36 28,20 28,20 
K8 hsa-miR-202#-002362 Undetermined 
 
Undetermined 
 K9 hsa-miR-193b#-002366 29,16 12,56 28,47 28,47 
K10 hsa-miR-497#-002368 Undetermined 
 
39,70 39,70 
K11 hsa-miR-518e#-002371 Undetermined 
 
Undetermined 
 K12 hsa-miR-543-002376 22,06 5,45 27,24 27,24 
K13 hsa-miR-125b-1#-002378 30,17 13,57 29,05 29,05 
K14 hsa-miR-194#-002379 Undetermined 
 
Undetermined 
 K15 hsa-miR-106b#-002380 20,81 4,21 19,55 19,55 
K16 hsa-miR-302a#-002381 Undetermined 
 
39,20 39,20 
K17 hsa-miR-519b-3p-002384 30,09 13,49 29,52 29,52 
K18 hsa-miR-518f#-002387 Undetermined 
 
Undetermined 
 K19 hsa-miR-374b#-002391 36,31 19,71 33,03 33,03 
K20 hsa-miR-520c-3p-002400 27,03 10,42 26,31 26,31 
K21 hsa-let-7b#-002404 Undetermined 
 
39,87 39,87 
K22 hsa-let-7c#-002405 Undetermined 
 
29,51 29,51 
K23 hsa-let-7e#-002407 30,11 13,51 30,20 30,20 
K24 hsa-miR-550-002410 28,24 11,64 27,41 27,41 
L1 hsa-miR-593-002411 Undetermined 
 
Undetermined 
 L2 hsa-let-7f-1#-002417 Undetermined 
 
Undetermined 
 L3 hsa-let-7f-2#-002418 Undetermined 
 
33,23 33,23 
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L4 hsa-miR-15a#-002419 26,15 9,54 28,95 28,95 
L5 hsa-miR-16-1#-002420 25,59 8,99 27,31 27,31 
L6 hsa-miR-17#-002421 26,94 10,34 27,32 27,32 
L7 hsa-miR-18a#-002423 22,16 5,56 24,02 24,02 
L8 hsa-miR-19a#-002424 32,91 16,31 34,69 34,69 
L9 hsa-miR-19b-1#-002425 21,94 5,33 22,63 22,63 
L10 hsa-miR-625#-002432 21,95 5,35 24,76 24,76 
L11 hsa-miR-628-3p-002434 27,28 10,68 26,51 26,51 
L12 hsa-miR-20a#-002437 23,66 7,06 23,61 23,61 
L13 hsa-miR-21#-002438 31,88 15,27 30,77 30,77 
L14 hsa-miR-23a#-002439 35,09 18,49 33,78 33,78 
L15 hsa-miR-24-1#-002440 32,63 16,02 37,17 37,17 
L16 hsa-miR-24-2#-002441 30,40 13,80 26,44 26,44 
L17 hsa-miR-25#-002442 23,97 7,37 24,36 24,36 
L18 hsa-miR-26a-1#-002443 27,97 11,37 27,98 27,98 
L19 hsa-miR-26b#-002444 28,59 11,98 28,05 28,05 
L20 hsa-miR-27a#-002445 27,59 10,98 26,41 26,41 
L21 hsa-miR-29a#-002447 33,93 17,33 28,65 28,65 
L22 hsa-miR-151-5P-002642 23,44 6,84 21,72 21,72 
L23 hsa-miR-765-002643 33,75 17,15 31,52 31,52 
L24 hsa-miR-338-5P-002658 33,05 16,44 28,79 28,79 
M1 hsa-miR-620-002672 Undetermined 
 
Undetermined 
 M2 hsa-miR-577-002675 27,13 10,53 27,86 27,86 
M3 hsa-miR-144-002676 Undetermined 
 
Undetermined 
 M4 hsa-miR-590-3P-002677 25,80 9,20 25,52 25,52 
M5 hsa-miR-191#-002678 25,77 9,17 25,25 25,25 
M6 hsa-miR-665-002681 29,73 13,13 Undetermined 
 M7 hsa-miR-520D-3P-002743 27,74 11,14 28,31 28,31 
M8 hsa-miR-1224-3P-002752 36,81 20,20 Undetermined 
 M9 has-miR-1305-002867 31,87 15,26 31,31 31,31 
M10 hsa-miR-513C-002756 Undetermined 
 
Undetermined 
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M11 hsa-miR-513B-002757 Undetermined 
 
Undetermined 
 M12 hsa-miR-1226#-002758 23,78 7,18 24,83 24,83 
M13 hsa-miR-1236-002761 31,51 14,91 34,17 34,17 
M14 hsa-miR-1228#-002763 Undetermined 
 
Undetermined 
 M15 hsa-miR-1225-3P-002766 33,74 17,14 35,71 35,71 
M16 hsa-miR-1233-002768 27,49 10,89 26,56 26,56 
M17 hsa-miR-1227-002769 23,65 7,04 25,82 25,82 
M18 hsa-miR-1286-002773 Undetermined 
 
Undetermined 
 M19 hsa-miR-548M-002775 Undetermined 
 
Undetermined 
 M20 hsa-miR-1179-002776 26,64 10,04 30,74 30,74 
M21 hsa-miR-1178-002777 Undetermined 
 
Undetermined 
 M22 hsa-miR-1205-002778 Undetermined 
 
Undetermined 
 M23 hsa-miR-1271-002779 21,59 4,98 22,22 22,22 
M24 hsa-miR-1201-002781 24,79 8,19 23,50 23,50 
N1 hsa-miR-548J-002783 36,30 19,69 36,83 36,83 
N2 hsa-miR-1263-002784 Undetermined 
 
Undetermined 
 N3 hsa-miR-1294-002785 Undetermined 
 
Undetermined 
 N4 hsa-miR-1269-002789 Undetermined 
 
24,74 24,74 
N5 hsa-miR-1265-002790 Undetermined 
 
Undetermined 
 N6 hsa-miR-1244-002791 24,28 7,68 26,99 26,99 
N7 hsa-miR-1303-002792 28,71 12,11 29,73 29,73 
N8 hsa-miR-1259-002796 Undetermined 
 
Undetermined 
 N9 hsa-miR-548P-002798 Undetermined 
 
34,94 34,94 
N10 hsa-miR-1264-002799 Undetermined 
 
Undetermined 
 N11 hsa-miR-1255B-002801 31,08 14,47 29,58 29,58 
N12 hsa-miR-1282-002803 29,62 13,02 31,26 31,26 
N13 hsa-miR-1255A-002805 Undetermined 
 
32,83 32,83 
N14 hsa-miR-1270-002807 Undetermined 
 
25,77 25,77 
N15 hsa-miR-1197-002810 27,35 10,75 37,45 37,45 
N16 hsa-miR-1324-002815 Undetermined 
 
Undetermined 
 N17 hsa-miR-548H-002816 Undetermined 
 
Undetermined 
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N18 hsa-miR-1254-002818 24,10 7,50 24,51 24,51 
N19 hsa-miR-548K-002819 37,50 20,90 Undetermined 
 N20 hsa-miR-1251-002820 35,25 18,65 Undetermined 
 N21 hsa-miR-1285-002822 32,37 15,77 30,83 30,83 
N22 hsa-miR-1245-002823 Undetermined 
 
Undetermined 
 N23 hsa-miR-1292-002824 32,82 16,22 33,75 33,75 
N24 hsa-miR-1301-002827 31,89 15,28 26,86 26,86 
O1 hsa-miR-1200-002829 Undetermined 
 
Undetermined 
 O2 hsa-miR-1182-002830 Undetermined 
 
Undetermined 
 O3 hsa-miR-1288-002832 38,20 21,59 39,97 39,97 
O4 hsa-miR-1291-002838 30,00 13,39 30,40 30,40 
O5 hsa-miR-1275-002840 21,29 4,69 21,72 21,72 
O6 hsa-miR-1183-002841 26,72 10,11 26,39 26,39 
O7 hsa-miR-1184-002842 Undetermined 
 
Undetermined 
 O8 hsa-miR-1276-002843 28,01 11,41 29,31 29,31 
O9 hsa-miR-320B-002844 23,85 7,24 21,66 21,66 
O10 hsa-miR-1272-002845 Undetermined 
 
36,61 36,61 
O11 hsa-miR-1180-002847 21,08 4,47 22,03 22,03 
O12 hsa-miR-1256-002850 Undetermined 
 
38,00 38,00 
O13 hsa-miR-1278-002851 Undetermined 
 
Undetermined 
 O14 hsa-miR-1262-002852 36,91 20,30 32,63 32,63 
O15 hsa-miR-1243-002854 25,26 8,66 26,64 26,64 
O16 hsa-miR-663B-002857 31,98 15,38 32,65 32,65 
O17 hsa-miR-1252-002860 Undetermined 
 
Undetermined 
 O18 hsa-miR-1298-002861 Undetermined 
 
Undetermined 
 O19 hsa-miR-1290-002863 25,31 8,71 22,21 22,21 
O20 hsa-miR-1249-002868 29,22 12,61 29,56 29,56 
O21 hsa-miR-1248-002870 31,69 15,09 30,05 30,05 
O22 hsa-miR-1289-002871 Undetermined 
 
Undetermined 
 O23 hsa-miR-1204-002872 Undetermined 
 
Undetermined 
 O24 hsa-miR-1826-002873 Undetermined 
 
Undetermined 
 
Dottorato di ricerca in Genetica e Biologia Molecolare 
 Pag. 131  
P1 hsa-miR-1304-002874 Undetermined 
 
Undetermined 
 P2 hsa-miR-1203-002877 Undetermined 
 
Undetermined 
 P3 hsa-miR-1206-002878 Undetermined 
 
Undetermined 
 P4 hsa-miR-548G-002879 Undetermined 
 
Undetermined 
 P5 hsa-miR-1208-002880 36,79 20,18 30,00 30,00 
P6 hsa-miR-548E-002881 37,11 20,51 Undetermined 
 P7 hsa-miR-1274A-002883 18,80 2,19 20,19 20,19 
P8 hsa-miR-1274B-002884 15,88 -0,72 16,45 16,45 
P9 hsa-miR-1267-002885 26,85 10,25 26,88 26,88 
P10 hsa-miR-1250-002887 Undetermined 
 
35,64 35,64 
P11 hsa-miR-548N-002888 Undetermined 
 
Undetermined 
 P12 hsa-miR-1283-002890 Undetermined 
 
Undetermined 
 P13 hsa-miR-1247-002893 27,82 11,22 23,69 23,69 
P14 hsa-miR-1253-002894 30,60 14,00 32,37 32,37 
P15 hsa-miR-720-002895 15,40 -1,21 16,34 16,34 
P16 hsa-miR-1260-002896 24,40 7,80 25,53 25,53 
P17 hsa-miR-664-002897 27,22 10,61 26,32 26,32 
P18 hsa-miR-1302-002901 39,64 23,03 Undetermined 
 P19 hsa-miR-1300-002902 30,30 13,70 30,51 30,51 
P20 hsa-miR-1284-002903 Undetermined 
 
Undetermined 
 P21 hsa-miR-548L-002904 35,69 19,09 33,13 33,13 
P22 hsa-miR-1293-002905 Undetermined 
 
Undetermined 
 P23 hsa-miR-1825-002907 Undetermined 
 
Undetermined 
 P24 hsa-miR-1296-002908 29,12 12,51 26,80 26,80 
 
